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ABSTRACT 
 
 
For the past years, radical prostatectomy (RP) has been the treatment of choice for locally advanced 
prostate cancer (PC) because of its high accuracy in tumor removal. However, the surgical techniques 
performed tend to be invasive, with a complete removal of the proximal lisso-sphincter and partial 
removal of the distal rhabdosphincter. Whereas the former has been related with maintenance of 
continence at rest, the latter is related with active continence. Between 4 to 69 % [1] of patients 
undergoing RP develop urinary incontinence, with a reported decrease in quality of life. This can be a 
consequence, not only from the surgical technique used, but from other factors including the competence 
of the sphincter function, that it is expected to decrease with age [2]. It is important to find preoperative 
imaging biomarkers that can help predict the risk of the patient developing postoperative urinary 
incontinence. The TransDouglas project, approved by the Ethics Committee of Champalimaud 
Foundation since July 2018, aims at validating the implementation of a new surgical procedure for RP, 
which is an improved version of the robotic-assisted laparoscopic radical prostatectomy (RALRP) 
procedure. Preoperative anatomical parameters are extracted from the T2-weighted magnetic resonance 
imaging (MRI) that can be related with urinary incontinence after the new surgical technique, and to 
construct a model that can help predict the likely time until urinary continence recovery. 
 
Diffusion tensor imaging (DTI) is a MRI-based technique that allows the quantification of anisotropic 
movement of water molecules. It has been proven [3] that this technique can be used to visualize the 
microarchitecture of the urethral sphincters, and to extract relevant diffusion metrics. DTI metrics can 
be incorporated in the model to predict urinary incontinence recovery after RP. Considering this, an 
addendum to the TransDouglas project that requests the acquisition of an additional DTI sequence to 
the standard multiparametric (mpMRI) of the prostate has been approved this January, enabling the use 
of DTI to study the microarchitecture of the urethral sphincters in vivo and non-invasively. However, 
since parameters of sphincter function significantly change with age [2], it is important to study the 
influence of patient age at scan on these parameters prior to predicting the likely chance of continence 
recovery after RP. Therefore, the main goal of this thesis was to investigate age-related differences in 
DTI metrics of the male urethral sphincter complex. Furthermore, the influence of a prostate condition, 
including PC and benign prostatic hyperplasia (BPH), was studied.  
 
The proximal and distal sphincters, as well as the membranous urethra, were reconstructed for 95 
subjects by using the deterministic tractography algorithm in DSIStudio software [4]. DTI metrics were 
extracted including tract length and density, fractional anisotropy (FA), mean diffusivity (MD), axial 
diffusivity (AD) and radial diffusivity (RD) and additional histogram parameters for each DTI metric, 
namely standard deviation, median, trimmed mean, median absolute deviation, minimum, maximum, 
range, skewness, kurtosis, standard error and the 5th, 25th, 75th and 95th percentiles. The influence of 
subject motion and eddy currents corrections on the extracted DTI metrics was investigated. Linear 
regressions and Pearson or Spearman correlations were performed between age and each of the DTI 
metrics. Additionally, analysis of variance (ANOVA), or the non-parametric Kruskal-Wallis test, were 
used to compare DTI metrics between four age groups (from 50 to 59, 60 to 69, 70 to 79 and 80 to 89 
years old). For a subset of the 69 subjects with a confirmed diagnosis for PC, BPH and the absence of 
any of both, ANOVA testing was used to compare between disease groups, and t-tests, or the non-
parametric Wilcoxon test, to compare between cancer status. For statistically significant ANOVA test 
results, post-hoc t-tests were used to investigate the groups between which the difference lied.  
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No statistically significant differences were found on DTI metrics with and without motion and eddy 
currents corrections, so the non-corrected DTI data was used for the subsequent analysis. In this study, 
it was found that MD and RD distributions statistical significantly changed with age. In particular, older 
subjects evidenced lower RD kurtosis in the proximal sphincter, lower MD maximum in the distal 
sphincter and higher MD median absolute deviation in the membranous urethra. On the other hand, 
further investigations are needed to understand if the presence of a prostate condition affects the DTI 
metrics of the sphincters and membranous urethra.  
 
This project was the first to examine age related differences in the urethral sphincter complex using 
DTI, as well as, the first time a DTI sequence for the prostate was implemented at Champalimaud Centre 
for the Unknown (CCU). It was concluded that age should be used as a covariate in a model that makes 
use of DTI biomarkers representative of the male urethral complex microstructure to predict the likely 
time of post-surgical continence recovery. Ultimately, this investigation should be a starting point for 
helping clinicians in the prediction of the risk of complications for each patient before undergoing RP, 
and balance the advantages and disadvantages comparing with other available treatment options for PC. 
 
 
 
Keywords: “Diffusion tensor imaging”, “tractography”, “urethral sphincter”, “age” and “prostate 
cancer”. 
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RESUMO 
 
 
Segundo dados de 2016, no sexo masculino e em países desenvolvidos, o cancro da próstata foi o cancro 
que registou maior incidência [5]. Após uma deteção através do aumento da evolução dos níveis do 
antigénio específico da próstata (PSA) no sangue e/ou de realização do teste do toque retal, o método 
de diagnóstico mais comum é a biópsia, que pode ser auxiliada por ultrassons ou por ressonância 
magnética multiparamétrica. A escolha do tratamento adequado para cada paciente depende do estadio 
da doença e das suas preferências individuais, que geralmente pretendem equiponderar a esperança de 
vida para o paciente e a qualidade de vida após tratamento. Geralmente, as opções de tratamento mais 
adequadas para um paciente com PSA > 10 ng/mL e nódulos palpáveis são: acompanhamento e 
tratamento dos sintomas à medida que estes surgem, radioterapia ou braquiterapia, e cirurgia [6]. A 
última opção, em particular a prostatectomia radical, tem demonstrado maior precisão na remoção de 
tecido maligno e no aumento da esperança média de vida para os pacientes operados [7]. Mais 
recentemente, técnicas laparoscópicas convencionais têm vindo a ser substituídas por técnicas robóticas 
que oferecem maiores vantagens no pós-operatório. No entanto, a incontinência urinária e a disfunção 
erétil continuam a ser complicações reportadas por uma percentagem significativa de pacientes 
submetidos a cirurgia. Relativamente ao primeiro, afeta cerca de 4 a 69 % dos pacientes [1], e a sua 
ocorrência está intimamente ligada à remoção do esfíncter proximal ou liso, que ocorre aquando da 
remoção da próstata, e consequente dano no esfíncter distal ou rabdoesfíncter.  
 
A construção de um modelo preditivo da recuperação da continência pós-cirúrgica com base na 
utilização de biomarcadores do esfíncter, pode permitir aos prospetivos pacientes uma escolha 
ponderada do tipo de tratamento. No entanto, é sabido que a microestrutura do esfíncter varia com a 
idade [2], logo é necessário conhecer o padrão de variação dos biomarcadores do esfíncter com a idade, 
no sentido de avaliar a recuperação pós-cirúrgica da continência.  
 
Para estudar a microestrutura do esfíncter têm sido utilizadas diversas técnicas in vivo [8]–[13] que, no 
entanto, não fornecem informação tridimensional da estrutura e orientação das fibras que o compõem. 
Contrariamente, imagem por tensor de difusão (DTI) é uma técnica não invasiva baseada em ressonância 
magnética que permite quantificar o movimento das moléculas de água nos tecidos, através da aplicação 
de gradientes em várias direções não colineares [14]. Relacionando o gradiente aplicado com o sinal 
medido, obtém-se em cada voxel informação sobre a magnitude e direção da difusão. A partir da 
diagonalização do tensor de difusão é possível calcular eigenvalues e eigenvectors. Enquanto que os 
últimos refletem a direccionalidade, os primeiros quantificam a magnitude da difusão e combinados 
entre si permitem obter um conjunto de métricas – que inclui a anisotropia fracional (FA), difusibilidade 
axial (AD), difusibilidade média (MD) e  difusibilidade radial (RD) – que permitem estudar a 
organização estrutural das fibras. Apesar das aplicações de DTI se focarem essencialmente em estudos 
de conectividade da substância branca do cérebro, têm progressivamente sido alargadas ao estudo de 
outros órgãos, como o rim [15], o coração [16] e a próstata. Relativamente ao uso de DTI para o estudo 
da próstata, esta técnica tem sido utilizada para estudar este órgão em condições normais [17] e para 
definir métricas que permitam distinguir tecido saudável de tumoral [18]. Ademais, estudos têm 
avaliado os feixes neuro-vasculares da próstata antes e após a cirurgia e correlacionado com a disfunção 
erétil pós-prostatectomia radical [7]. Para além de um estudo que investigou o esfíncter uretral feminino 
usando DTI [19], que se tenha conhecimento, existe apenas um estudo que conseguiu utilizar DTI para 
estudo da microarquitectura do esfíncter masculino em sujeitos jovens e sem patologia [3].  
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Assim, o principal objetivo da presente tese de mestrado é investigar variações derivadas da idade no 
complexo do esfíncter uretral, que compreende os esfíncteres proximais e distais e a uretra membranosa 
– correspondente ao segmento da uretra que se estende desde o ápice da próstata até ao bulbo peniano. 
No sentido de estudar o efeito da presença de uma condição da próstata, incluindo cancro da próstata e 
hiperplasia benigna da próstata (HBP), a variação das métricas de DTI do esfíncter para o grupo de 
pacientes diagnosticados foi também avaliada. Como objetivo secundário, que teve importância na etapa 
de processamento dos dados de DTI, foi investigado se a correção de movimento durante a aquisição e 
correção de correntes de Foucault afetava significativamente as métricas de DTI em estudo, para cada 
uma das estruturas. 
 
Para tal, os esfíncteres proximal e distal, bem como a uretra membranosa, foram reconstruídos para 95 
indivíduos usando o algoritmo determinístico de tractografia no software DSIStudio [4]. Previamente 
foram definidas manualmente um conjunto de regiões de interesse nos mapas coloridos de FA para os 
esfíncteres proximal e distal, e na imagem anatómica em T2 para a uretra membranosa. Para a 
tractografia, foram otimizados alguns parâmetros segundo uma abordagem de tentativa e erro, que 
acabou por estabelecer um valor limite de anisotropia fracional de 0.15, e um limite angular de 75º e 
45º, respetivamente para os esfíncteres e para a uretra. As métricas de DTI foram extraídas para cada 
uma das estruturas reconstruídas, incluindo o comprimento e densidade das fibras, FA, AD, MD e  RD 
e parâmetros adicionais do histograma para cada métrica de DTI, ou seja, desvio padrão, mediana, média 
aparada, desvio absoluto mediano, mínimo, máximo, amplitude, assimetria, curtose, erro padrão e os 
percentis 5, 25, 75 e 95. A influência do movimento e da presença de correntes de Foucault nas métricas 
de DTI extraídas foram investigadas. Regressões lineares e correlações de Pearson ou Spearman foram 
realizadas entre a idade e cada uma das métricas de DTI. Além disso, uma análise de variância 
(ANOVA) – ou o equivalente teste não paramétrico de Kruskal-Wallis –, foram realizados para 
comparar métricas de DTI entre quatro faixas etárias (de 50 a 59, 60 a 69, 70 a 79 e 80 a 89 anos). Para 
um subconjunto dos 69 indivíduos com diagnóstico confirmado de cancro de próstata, HBP ou da 
ausência de qualquer um dos dois, o teste ANOVA foi usado para comparar entre grupos de doença. 
Adicionalmente, testes t-student – ou o teste não paramétrico de Wilcoxon – foram utilizados para 
comparar a presença vs. ausência de cancro. Para resultados estatisticamente significativos do teste 
ANOVA, foram posteriormente empregues testes t-student para investigar entre que grupos se 
encontrava a diferença. 
 
Não foram encontradas diferenças estatisticamente significativas nas métricas de DTI com e sem 
correção de movimento e correntes de Foucault, logo, os dados de DTI sem correção foram utilizados 
para a análise subsequente. Neste estudo, verificou-se que as distribuições de MD e RD variaram 
significativamente com a idade. Em particular, indivíduos mais velhos evidenciaram menor curtose da 
RD no esfíncter proximal, menor valor máximo de MD no esfíncter distal e maior desvio absoluto 
mediano de MD na uretra membranosa. Por outro lado, são necessárias investigações adicionais para 
entender se a presença de uma condição da próstata pode afetar as métricas de DTI dos esfíncteres e da 
uretra membranosa. Tal acontece, pois os resultados obtidos neste estudo para a presença de doença 
estão limitados pela heterogeneidade da amostra em termos das diferentes condições que cada indivíduo 
pode apresentar.  
 
Julga-se que este estudo foi o primeiro a identificar variações com a idade nas métricas de DTI do 
esfíncter. Além disso, definiu a inclusão de uma sequência de DTI à ressonância magnética 
multiparamétrica da prática clínica da Fundação Champalimaud. Por se tratar de um estudo prospetivo, 
foi possível definir os parâmetros de aquisição – nomeadamente o valor de b (em s/mm2), o número de 
direções da aplicação do gradiente, o número de cortes adquiridos e a extensão da aquisição - ótimos 
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para a visualização das estruturas do complexo uretral masculino, com o melhor compromisso entre 
duração da aquisição (em minutos) e a resolução espacial (em milímetros). Esta nova sequência só 
começou a ser incluída na clínica desde Janeiro 2019, o que representa cerca de 14 pacientes operados, 
dos 45 diagnosticados com cancro da próstata. Assim que for possível aumentar a amostra de pacientes 
operados com um intervalo de tempo pós-cirúrgico de 3 a 6 meses, será possível utilizar os resultados 
dos testes de incontinência, os dados de DTI do esfíncter corrigidos da idade e as medidas do 
comprimento da uretra em T2, para prever o tempo de recuperação de continência pós-cirúrgica. No 
futuro, esperamos poder extrair os biomarcadores de DTI para o complexo do esfíncter uretral de cada 
paciente e usá-los como um preditor da taxa de incontinência pós-cirúrgica. No entanto, é importante 
que este modelo tenha em conta alterações nas métricas de DTI do complexo uretral masculino que são 
influenciadas pelo envelhecimento. Esse modelo preditivo pode orientar os pacientes na escolha 
informada da melhor opção de tratamento personalizado para tratar o tumor da próstata e, 
simultaneamente, proporcionar uma qualidade de vida satisfatória. 
 
 
 
Palavras-chave: “Imagem por tensor de difusão”, “tractografia”, “esfíncter uretral”, “idade” e “cancro 
da próstata”. 
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1 INTRODUCTION 
 
Urinary incontinence is a post-surgical complication that diminishes prostate cancer (PC) patients 
quality of life. The main focus should be, not on the treatment of urinary incontinence, but rather on its 
prediction before occurrence. Individual preoperative imaging parameters of the male urethral sphincter 
complex microstructure can potentially be used to predict the rate of post-surgical continence recovery. 
However, since its microstructure is thought to change with age, it is important to access age-related 
differences in the male urethral sphincter complex. 
1.1 Objectives and hypothesis 
 
To our knowledge, there is one published study that has successfully shown that diffusion tensor 
imaging (DTI) can be used to study the male urethral sphincter complex [3]. After feasibility of urethral 
sphincters’ DTI has been proven for eleven healthy young subjects, we aim at addressing a gap in the 
literature with the investigation of age and disease related changes on DTI metrics of older male subjects 
with (suspected) PC, benign prostatic hyperplasia or without any prostate condition. Additionally, there 
is no stablished consensus on whether motion and eddy currents corrections should be performed on 
DTI of the male urethral complex and which is the recommended method, due to the limiting number 
of existing studies.  
Hereupon, this thesis has the following objectives: 
1) Studying the influence of motion and eddy currents correction on the analysis of DTI metrics 
of the male urethral sphincter complex;  
2) Investigating whether DTI metrics significantly change in the presence of a prostate condition, 
namely PC and benign prostatic hyperplasia (BPH); 
3) Investigating age-related differences in the male urethral sphincter microarchitecture, studying 
whether there is a linear relationship or correlation between age and DTI metrics of the sphincter 
complex, and by comparing DTI metrics by age decades – which is the current thesis main goal.  
Regarding 3), since it is expected a decrease in fiber integrity with age, it is hypothesized a reduction in 
fractional anisotropy (FA) with increasing age. Also, it is hypothesized a reduced tract density and length 
in older subjects, reported by tractography findings. These findings may help understanding the effect 
of ageing in the male urethral sphincter microstructure, in order to be able to weight in the influence of 
age when predicting the rate of recovery from postoperative urinary incontinence. 
The current master thesis has been structured to first cover the relevant theory on the anatomy of the 
prostate and adjacent structures of the male pelvic complex, prostate conditions focusing on PC, 
postoperative complications following radical prostatectomy (RP) centering on urinary incontinence, 
and several aspects related with diffusion tensor imaging (DTI) as a non-invasive technique to study the 
sphincters’ microarchitecture. In chapter 3, the current state-of-the-art for DTI is addressed, from brain 
applications, passing through studies of DTI on pelvic organs, to applications on the prostate, 
periprostatic neurovascular fibers (PNFs) and the urethral sphincter complex. Afterward, in chapter 4, 
the materials and methods used for data acquisition, imaging processing, tractography and statistical 
analysis are presented. In the following chapter, the results are presented for addressing each one of the 
study goals, related with the effect of motion and eddy currents corrections, as well as the fiber tracking 
results analyzed both with age and disease. Lastly, the discussion and study conclusions, limitations, 
and future work are presented in chapter 6. 
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2 BACKGROUND 
 
2.1 Normal prostate and its conditions 
2.1.1 Prostate anatomy 
 
The prostate is an accessory gland of the size and shape of a walnut, with about 4 cm long and 2 cm 
wide, that is part of the male reproductive system [20]. During ejaculation, this gland contracts to 
accomplish its main function of secreting a fluid to nourish and protect sperm, contributing to 30% of 
the semen. This gland is located inferior to the urinary bladder, superior to the penile bulb and anterior 
to the rectum. If one is to divide the prostate into three thirds in the superior-inferior direction, it is 
possible to consider, respectively, the base (right below the bladder), the midgland and the apex [21]. 
 
An extra prostatic capsule incompletely encircling the prostate, made of smooth muscle on the internal 
portion and fibrous connective tissue on the external portion, can be acknowledged. However, 
histological evaluation confirms the nonexistence of a real prostate capsule (in return one can designate 
it as a pseudo capsule), since this tissue is inseparable from prostatic stroma. 
 
This gland is crossed by the prostatic segment of the urethra, that can be used as a central anatomical 
reference point to locate each one of the prostate regions [22]. Considering the zonal anatomy of the 
prostate, it is possible to divide it into four histologically and anatomically distinct zones: peripheral 
zone (PZ), transition zone (TZ), central zone (CZ) and anterior fibromuscular stroma (AFS). The 
peripheral zone constitutes 70% of glandular tissue and it is located on the posterior and lateral side of 
the prostate, radiating laterally to the urethra. The transition zone is crossed by the prostatic urethra and 
constitutes only 5% of the prostate glandular tissue. Posteriorly to the transition zone, is the central zone 
that follows left and right ejaculatory ducts, branching laterally into the prostate base. This region 
constitutes 25% of the glandular tissue. Finally, the non-glandular anterior fibromuscular stroma is the 
smaller area that occupies the totality of the anterior surface of the prostate. The prostate zonal anatomy 
can be depicted in Figure 2.1, that also shows how each third of the prostate can be subdivided into 6 
sectors on each side.  
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Figure 2.1 Zonal anatomy of the prostate gland, showing the peripheral zone (PZ) in pink, the central zone (CZ) in green, the 
transition zone (TZ) in yellow, the urethral sphincter (US) in brown and the anterior fibromuscular stroma (AFS) in blue. On 
the right side of the image, it is possible to see the seminal vesicles, the urethra and the subdivision of the prostate base, 
midgland and apex into 12 sectors described on Table 2.1. – adapted from [23]. 
 
 
Table 2.1 Acronyms for the 6 sectors repeated on both sides of base, midgland and apex. 
Base 
AS Anterior fibromuscular stroma 
TZa; TZp Anterior (a) and posterior (p) transition zone 
PZa; PZpl Anterior (a) and posterolateral (pl) peripheral zone 
CZ Central zone around the ejaculatory ducts 
Midportion 
AS Anterior fibromuscular stroma 
TZa; TZp Anterior (a) and posterior (p) transition zone 
PZa; PZpm; 
PZpl 
Anterior (a), posteromedial (pm) and 
posterolateral (pl) peripheral zone 
Apex 
AS Anterior fibromuscular stroma 
TZa; TZp Anterior (a) and posterior (p) transition zone 
PZa; PZpm; 
PZpl 
Anterior (a), posteromedial (pm) and 
posterolateral (pl) peripheral zone 
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2.1.2 Anatomy of other relevant structures of the male pelvic complex 
 
The seminal vesicles are two sac-shaped glands, divided into left and right, with about 5 cm long. Each 
gland has a capsule of both fibrous connective tissue and smooth muscle. The seminal vesicles 
contribute with about 60% of fluids to the semen [20]. 
 
The male urethral sphincter is composed by a continuous muscle around the urethra with variable 
thickness in cranial to caudal extension [24]. However, it forms a functional subdivision into two 
muscles, the lisso-sphincter and the rhabdosphincter (Figures 2.2 and 2.3). Whereas the lisso-sphincter 
(also known as proximal sphincter) is composed of smooth muscle and forms a complete ring around 
the urethra, the rhabdosphincter (also known as distal sphincter) is composed of skeletal muscle and has 
a shape of a horseshoe, being thickest around the membranous urethra and less distinct near the bladder 
(in opposition to the proximal sphincter). The rhabdosphincter configuration may vary from an extended 
circular shape with over half circumferential orientation with limited proximal-distal length and 
thickness, to a restricted circular pattern such as a thin arc-like structure [25]. The primary function of 
the lisso-sphincter is maintaining continence at rest, whereas the rhabdosphincter has a dual 
genitourinary function, both related with erection and active continence - related with the forceful 
closure of the urethra in stress conditions [24]. 
 
 
Figure 2.2 Mid-sagittal male anatomy near the bladder and urethra, including a schematic on that section (a) and a 
magnetic resonance imaging (MRI) high-resolution proton density image on an increased field of view (FOV) (b) - adapted 
from [3]. 
 
Figure 2.3 Schematic neuroanatomy of the male urethral sphincter complex, including the bladder musculature (1), the 
perineal membrane (6), the prostate (7), and with particular attention to the following: the proximal (2) and distal (3) parts 
of the lisso-sphincter, the rhabdosphincter (4) and the prostatic part of rhabdosphincter (5) - adapted from [24]. 
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The levator ani fascia is composed of smooth muscle tissue, mostly with bulky and multilayered fibers 
[25]. In most men, it can be observed that the levator muscle is connected by a connective tissue mass 
with the urethral sphincter, the distal half portion of the prostate and the membranous urethra. Posteriorly 
to the membranous urethra, this muscle is also connected with the outer layer of the rectum (Figure 2.4).  
 
 
Figure 2.4 Gross slice of the pelvis showing the levator ani (LA) fascia and the urethral rhabdosphincter (URS). The URS 
and the puborectalis muscle (PR) are connected by a thick tissue mass (marked with white stars). The PR is also connected to 
the outer layer of the rectum (marked with black stars) In this figure it is also possible to observe the dorsal vein complex 
(DVC) and the MU (membranous urethra) – adapted from [25]. 
 
The neurovascular bundles comprise the association of nerves that supply the corpora cavernosa with 
arterial branches that come from the inferior vesicle artery and with veins [21]. This bundle appears 
bilaterally to the prostate and its function is intimately related with sexual function. 
 
 
2.1.3 Prostate conditions 
 
Most men during their lifetime, end up having some condition that affects the prostate. These can be 
benign, like prostatitis or BPH, or malignant, considering PC. The former is characterized as an 
inflammation of the prostate that can be caused by bacterial agents, and it is more easily treated through 
antibiotic administration. The other benign prostate condition, BPH, is mostly related with ageing, 
affecting more than 50 % of men over 60 years old and about 90% when they reach their eighties [26]. 
Not only ageing, but also infections and tumors can be a cause for this condition [20]. BPH is 
characterized by an enlargement of the prostate volume, where the majority of its growth occurs in the 
TZ. Looking from a molecular perspective, it was found that the prostate enlargement is related with 
higher concentrations of serum insulin-like growth factor 1.  
 
Normally, BPH is diagnosed through patient history, physical and rectal examinations, investigations to 
exclude urinary tract infection and renal damage, and urinary flow measurement. Regarding treatment, 
active surveillance in combination with urodynamic pressure/flow studies are recommended priory to 
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any kind of invasive treatment that involves the removal of obstructing tissue, such as laser therapy or 
transurethral resection of the prostate. This procedure takes about 20-30 minutes, considering a gland 
of 30 g, and has a small mortality rate of around 0.2-0.4 % [26].  
 
Apart from detrusor muscle and bladder overactivity, age-related smooth muscle dysfunction, and 
neurological factors, prostatitis and BPH are some of the main causes for lower urinary tract symptoms 
(LUTS) in men. LUTS are not defined as a disease, but rather as a symptom-complex that affects ageing 
women and men. Main symptoms, that are frequently accepted by the elderly as normal but significantly 
impact their quality of life, can be categorized into voiding symptoms - including hesitancy in urinating, 
poor urinary flow, sensation of incomplete bladder emptying, late urine dribbling and prolonged 
urination - and into storage symptoms - comprising frequent daytime voiding, nocturia, urgency in 
voiding and involuntary incontinence of urgency.  
 
2.1.4 Prostate cancer 
Epidemiology, Detection, Diagnosis and Staging  
 
Prostate cancer is a clinically heterogeneous disease and the most diagnosed cancer in men in the world 
(Figure 2.5), with approximately 1.4 million incident cases and 381,000 deaths in 2016 [5]. The 
incidence of PC has been increasing by 40% since 2006, due to a change in the age structure and size of 
the population, and due to an alteration in the age-specific incident rates. Prostate cancer represents the 
fifth most common cause of cancer death worldwide, with higher incidence in developed countries [27]. 
Particularly, while the odds of developing PC are of 1 in 16 for low-middle sociodemographic index 
countries, these are of 1 in 7 for countries with a high index [5].  
 
 
Figure 2.5 Absolute incident cases (in 2016) for male subjects, color encoded by cancer type. As we can see, PC (shown in 
purple) is the most incident cancer in men worldwide, and the one with a higher incidence in men in Portugal – adapted from 
[5]. 
Two risk factors clearly associated with PC are age, with 36.3 % of cancers being diagnosed between 
60 to 69 years old [28], and heredity, being PC a polygenic disease. Apart from these, other risk factors 
may play a role in this condition [29], including race (African individuals are more prone on developing 
PC), inflammation (having some chronical inflammatory process that may affect the prostate), hormones 
(specifically, patients that undergo hormonotherapy for suppression of male sexual hormones after 
puberty have a higher risk of developing PC), metabolic syndrome, diets based on certain vitamins and 
antioxidants that may serve as a protection on the development of cancer, smoking (cadmium in 
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circulatory system may increase the change of cellular oxidation) and physical activity (that increases 
overall quality of life, helping to minimize the risk of PC). Although the prevention is key in decreasing 
the incidence of some cancers, like lung cancer (through the control of tobacco exposure) and skin 
cancer (through the reduction of exposure to ultra-violet radiation), in PC the prevention efforts can be 
less effective. Additionally, the early signs and symptoms of PC are very rare. So, prevention should be 
done in conjunction with the utilization of early detection methods and better access to treatment.  
 
Detection of PC can be assessed by an increase in the prostate specific antigen (PSA) levels in the blood 
or by textural or consistency changes on the prostate’s posterior aspect of the PZ detected by the digital 
rectal exam (DRE). Although a PSA threshold of higher than 4.0 ng/mL is commonly used as an 
indicator for performing a PC diagnosis, PSA values can change with different factors, and there is no 
such thing as a normal/abnormal PSA test result [30]. For each case, patient characteristics should be 
incorporated in the evaluation of PSA test results, and the evolution of PSA levels over time should be 
monitored. 
 
The gold standard for diagnosis remains the biopsy, which consists on the analysis of prostate tissue 
samples from 10 to 12 different locations in a grid-like pattern, collected via transrectal ultrasound [6]. 
Then, the pathologist assigns a score, the Gleason grade, that reflects tumor aggressiveness by the sum 
of a primary score on the largest area of the tumor plus a score on the second largest area, each ranging 
from 1 (closer to healthy tissue) to 5 (closer to abnormal tissue). For instance, a Gleason score of 3 + 4 
(grade 2) is different from a Gleason score of 4 + 3 (grade 3). However, even the ultrasound-guided 
biopsy has the limitations of undetecting 21-28% of prostate tumors, as well as, of assigning a lower 
Gleason grade to 14-17% of cases. Combination of biopsies with other techniques, such as, new 
molecular biomarkers, measurement of PSA levels and multiparametric MRI (mpMRI) – including high 
resolution T1 and T2 weighted imaging, diffusion weighted imaging (DWI) and dynamic contrast 
enhanced (DCE) imaging – for a targeted biopsy, can help identify false negative cases. A targeted 
biopsy, meaning MRI fused with ultrasound, increases the correct stratification of patients, compared 
with a systematic prostate biopsy. Prostate metastases and PC recurrence – defined as a PSA > 0.2 
ng/mL after surgery – are usually diagnosed by cross-sectional body imaging with computed 
tomography, MRI or positron emission tomography with recently FDA approved radiotracers that have 
demonstrated activity on PC.  
 
Based on the mpMRI acquisition, a more standardized classification system was introduced in 2012, 
called the Prostate Imaging Reporting and Data System (PI-RADS) [21]. This classification system 
provides a score from 1 (very low) to 5 (very high) to each prostate lesion, according to the likelihood 
of a clinically significant PC. Depending on the prostate region, the PI-RADS category is assigned based 
on the characteristics of the lesion in a specific MRI sequence (as observed in Figure 2.6), namely, for 
lesions in the PZ the primary sequence used are the diffusion weighted imaging (DWI) or the apparent 
diffusion coefficient (ADC), while for the TZ is the T2-weighted imaging. Most prostate tumors (75 to 
85%) originate in the PZ [31], that appears as a thin layer of high signal intensity in the T2-weigthed 
imaging. It is less common (less than 25%) for cancer to be originated in the TZ – an heterogenous 
region of intermediate signal intensities –, and even less on the CZ or AFS (although tumors originated 
elsewhere can spread to these regions). The pseudo capsule, that appears as a hypointense line on the 
T2-weighted imaging, is considered to be useful as a reference to assess the extra prostatic extension of 
the tumor. 
 
Regarding the interpretation of prostate tumors on the mpMRI, these appear to be hypointense (dark) 
on the T2-weighted imaging and on the ADC map, and hyperintense (bright) on the DWI. In fact, 
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malignant cells create a restriction to diffusion (low ADC), translating in a high DWI signal, that is 
evidenced when using a higher b-value (at least 1400 s/mm2) that improves lesion conspicuity [21].  
 
 
 
Figure 2.6 PI-RADS assessment categories for lesions on each prostate region, PZ and TZ, based on the DWI/ADC and the 
T2-weighted image, respectively. To distinguish between similar lesions, other mpMRI sequences can be used as reference, 
such as the DCE image – adapted from [32]. 
 
Recent advances on diagnosis techniques, have allowed a better stratification of PC patients by risk, 
which is key to make a balanced choice on disease treatment [6]. Prostate tumors can be stratified by 
risk into very low, low, intermediate, high or very high, as proposed by the National Comprehensive 
Cancer Network. This risk stratification is done by a combination of the biopsy Gleason score, the PSA 
and the TNM (Tumor, Node, Metastasis) clinical staging – the latter is based on clinical and pathological 
findings and it is mainly divided into T1 (inapparent tumor), T2 (tumor confined to the prostate), T3 
(tumor extends through the prostate capsule), T4 (tumor invades other nearby structures), N0 (absence 
of regional lymph node metastasis), N1 (metastasis in regional lymph nodes), M0 (no distant metastasis) 
and M1 (distant metastasis). An accurate biopsy is of crucial importance for a correct risk stratification. 
Based on the risk stratification assigned to each patient, plus his individual preferences and values, 
clinicians can guide patients on the decision-making process regarding treatment type. 
 
Treatment of Prostate Cancer 
 
It is normally recommended that patients with a less aggressive prostate tumor, defined as a PSA < 10 
ng/mL or a Gleason score of 3 + 3, choose to be in active surveillance for PC [6]. This consists of a 
combination of techniques to regularly monitor the disease evolution, including PSA testing, physical 
examinations and prostate biopsies.  
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On the opposite side, patients with metastatic PC (including regional lymph node or distant metastases) 
are usually recommended an initial treatment of chemotherapy (using drugs like abiraterone, 
enzalutamide or others), that is commonly preferred over traditional hormonal therapy, like androgen 
deprivation therapy.  
 
On the intermediate side, patients with localized PC, with a PSA > 10 ng/mL and nodules palpable on 
DRE, mostly rely on expectant management, radiation and surgery as the available treatment options. 
Expectant management comprises both active surveillance and watchful waiting, that consists on 
treating disease symptoms with a palliative intent. Regarding curative approaches, radiation treatment 
can be done both by external radiotherapy or brachytherapy (through the implantation of radioactive 
seeds on the prostate), or through a procedure called RP. The latter has been considered the main choice 
for locally advanced PC, because of the accuracy in tumor excision [7]. 
 
Additionally, curative approaches generally offer a higher life expectancy, which is considered a 
predominant decision-making factor to patients [33]. Although in the past, RP was not recommended 
for older patients (>70 years old), this trend has been changing, mainly due to higher survival rates and 
better functional outcomes, related with increased life expectancy and advances in surgical techniques 
[34]. 
 
Postoperative complications following Radical Prostatectomy 
 
Despite significant improvements in the last years, severe post-surgical complications may still arise 
from RP, namely urinary incontinence and erectile dysfunction [35], that can significantly reduce the 
patient’s quality of life. While urinary incontinence is mostly related with the removal of the proximal 
lisso-urethral sphincter (even in the presence of an intact distal rhabdosphincter) [3], the recovery of 
erectile dysfunction after RP is mostly associated with the degree of PNFs sparing [36] - since 
periprostatic autonomic nerves are crucial for erectile function. Despite that, the mechanisms of post-
surgical urinary incontinence are still to be stablished, since they are known to be a result of the 
combined integrity between the proximal and distal sphincters and of surrounding prostate structures, 
including muscles and fasciae [37]. Urinary incontinence has been reported in 4 to 69 % of patients that 
undergo RP [1]. This wide range of reported incidence may be due to the evaluation tool used, the length 
of the follow-up chosen, and mainly, to the definition used to classify incontinence [38]. There are 
different forms of quantifying the patient’s continence, but traditionally, a definition of using zero pads 
per day is better correlated with the quality of life after RP [39]. This can be accessed among patients 
using the international consultation on incontinence questionnaire-short form (ICIQ-SF) score [40], that 
is presented to the patient at several time points after RP to evaluate the severity of urine leakage and 
impact on quality of life. Incontinence after RP is likely to emerge from multifactorial causes, including 
patient characteristics, preoperative continence status, urethral characteristics, detrusor function, and 
those related with the surgical technique [1]. Particularly, higher surgeon experience has been shown to 
reduce the rate of postoperative complications [35]. Regarding patient characteristics, the patient age at 
surgery has been considered a stablished predictor for urinary incontinence recovery. Although some 
studies have not found a statistically significant trend between post-surgical continence recovery rate 
and ageing [37], most studies have correlated increasing patient age at surgery with higher risk of urinary 
incontinence. It was found that while 3% of patients aged below 60 show complete incontinence after 
surgery, this percentage is more that 20% in patients older than 70 years old [2]. A recent study [34] has 
found that younger patients (age <= 70 years old) have a higher urinary continence recovery rate after 
3 and 12 months, comparing with older patients (age > 70 years old), although the rate gap between age 
groups has decreased during the study period (2004 to 2015). This same study aimed at defining the 
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predictor factors of post-surgical urinary incontinence following RP for the two different age groups. 
They have found that, while different predictors can be used for younger patients, namely, age, robot-
assisted RP, prostate volume, membranous urethral length (MUL) and neurovascular bundles’ sparing, 
only the age and MUL were found to be predictors for continence recovery in older male.  
 
Regarding urethral characteristics, they are the result of sphincter incompetence, changes in urethral 
length or preoperative strictures [41]. In fact, the proximal sphincter is completely removed during RP, 
which can explain the high risk of postoperative urinary incontinence. So, post-operative continence 
mostly relies on the rhabdosphincter [41]. 
 
Currently, the available treatment options for post-operative incontinence comprise conservative 
approaches - pelvic floor exercises or biofeedback -, pharmacotherapy, transurethral bulking agents or 
artificial urinary sphincter and male slings [1]. However, the goal of the urologic surgeon should be, not 
on the treatment of postoperative incontinence, but rather on the reduction of its rate, before occurrence 
[41]. Some studies [42] argue that the solution to reduce the complication should focus on the alteration 
of the technical aspects of the surgical procedure. For instance, this study [43] has introduced a method 
for reconstructing the rhabdosphincter during the RP performed with the robotic system. Traditional 
laparoscopic procedures have been replaced by RALRP, a robotic surgical system offering 7 degrees of 
freedom, tridimensional magnification and scaling of movements [39]. This technique has been gaining 
an increased acceptance for the treatment of localized PC - with less blood losses and transfusion 
rates, better perioperative outcomes and possible faster recovery of urinary continence and erectile 
function [39]. 
 
The TransDouglas project aims at validating the efficacy of a new surgical procedure for RP, which is 
the improved version of RALRP. This technique, called Retzius-sparing robotic assisted laparoscopic 
RP, proposed by Galfano [44], spares the retropubic space by passing through the Douglas pouch. By 
doing that, it is expected a faster postoperative recovery of urinary continence, since most anatomical 
structures involved in continence remain intact [45]. Particularly, the reduced damage of the PNFs and 
the preservation of the distal rhabdosphincter can lead to better post-operative outcomes regarding, 
respectively, erectile function and urinary incontinence. 
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2.2 Diffusion tensor imaging 
 
Previously, a study [3] has shown the feasibility of visualizing muscle fibers of the prostate sphincters 
using diffusion tensor imaging (DTI), a useful technique to understand tissue microarchitecture, in terms 
of fibers integrity and directionality. In this section, a theoretical introduction to DTI is presented, 
followed by a brief introduction to tractography methods, a popular method used for fiber reconstruction 
and 3D visualization of fibers, and to different steps of the DTI processing and analysis workflow, 
including motion and eddy currents correction methods. 
2.2.1 Theoretical background 
Brownian motion 
The terms “Brownian motion” or diffusion can be used to describe the random thermal movement of 
molecules [46]. Einstein has described mathematically this physical property at a given temperature by 
Equation 2.1. 〈*+〉 = 6	#	.          (2.1) 
where the first term represents the mean squared displacement of the molecules, # is the diffusion 
coefficient, a constant that relates diffusive flux to a concentration gradient, and . the diffusion time. 
The diffusion coefficient (#), accounting for several factors that influence diffusion in living systems, 
can be referred to as the ADC [47]. The ADC for water molecules at a body temperature of 37° C is 3 × 1034	mm+/s [48]. Considering a diffusion time in the order of milliseconds according to the typical 
MR measurement time (10–100 ms) [49], water molecules will travel a distance in the order of 
micrometers. This displacement is in the same order of magnitude as the cellular dimensions, which 
makes it possible to access the microstructural properties of biological tissues. 
 
Diffusion weighted imaging 
Diffusion weighted imaging (DWI) is sensitive to the Brownian motion of water molecules in biological 
tissues, and so, it can be used to explore tissues’ microarchitecture [50]. The diffusion-weighted pulse 
sequence corresponds of two gradients, equal in magnitude, that are applied to the T2-weighed spin-
echo sequence (Figure 2.7). These gradients are applied before and after the 180° refocusing 
radiofrequency pulse, symmetrically centered at it, which is known as the Stejskal-Tanner diffusion 
encoding [51].  
 
 
Figure 2.7 The Stejskal-Tanner imaging sequence, where G represents the magnitude of the applied gradient, ! the duration 
of each diffusion gradient and ∆ the duration between the application of the two gradients - adapted from [52]. 
 
G G 
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Whereas the first applied gradient is responsible for a phase shift in proton spins, the second one will be 
cancelling the gained phase shift for stationary molecules. However, diffusing molecules will not allow 
the rephasing by the second gradient, since they are changing position during its application [50]. Faster 
molecules travel a wider distance, which will translate in more signal loss which is represented by darker 
image voxels [53]. So, image contrast in DWI is based on the differences in diffusion magnitude. The 
diffusion-weighted contrast can be described by the Stejskal-Tanner equation (Equation 2.2) which 
explains the signal intensity decrease due to Gaussian diffusion. 
 89 = 8:	;3	<	=>?@          (2.2)  
where 89 refers to the diffusion-weighted signal intensity at a given voxel with gradients applied along 
direction i, 8: refers to the original signal or the diffusion-weighted signal intensity when no gradients 
are applied, the b-value refers to the LeBihan’s factor [54] that describes the diffusion sequence, gradient 
strength and physical constant, and A#B9 is the A#B at direction C. For rectangular gradient pulses, the 
b-value can be obtained by Equation 2.3. D = E+	F+	!+ 	G∆	−	I4J          (2.3) 
where E is the gyromagnetic ratio, F the gradient’s amplitude, ! the duration of each diffusion gradient 
and ∆ the duration between the application of the two gradients.  
 
It is important to note, using Stejskal-Tanner equation, that an increase in the b-value increases the 
degree of diffusion weighting and it is related with a loss of signal intensity along the direction of the 
applied gradients.  
 
Anisotropy vs isotropy 
Depending on tissues’ properties – type, integrity, architecture and presence of barriers – water 
molecules will present different diffusivity behaviors [14]. The water molecules in a wider space move 
randomly in all directions, known as isotropic diffusion. On the other hand, if the movement is confined 
along a particular direction and molecules will no longer move equally in all directions, it is called 
anisotropic diffusion. The example of the brain can be used for a better analogy, where the water 
molecules in the cerebrospinal fluid have an isotropic movement and in the white matter this movement 
is anisotropic. Whereas in the first case, the diffusion is similar in all directions, in the second, the 
diffusion is higher along the tract but reduced in the other directions. So, there is a need of applying 
gradients in more than one diffusion-encoding directions to characterize anisotropic diffusion. These 
directions should be noncollinear, that is, not applied on the same line. 
 
Diffusion tensor 
In order to understand the anisotropy profile in 3D, the acquisition of at least six image sets in 
noncollinear directions - and one baseline image for a null b-value - is needed. Having six different 
signal intensities for noncollinear gradient directions, allows the utilization of a multivariate linear 
regression to calculate the diffusion tensor (Figure 2.8). The diffusion tensor provides a rotationally 
invariant description of the shape of water diffusion and uses a Gaussian model [53]. 
 
Diffusion tensor imaging (DTI) [55] is a non-invasive MRI-based technique that models diffusion using 
the diffusion tensor, a 3 x 3 positive symmetric matrix of vectors. In each voxel we get the information 
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about direction and magnitude of diffusion, by relating the measured signal with the applied gradient. 
This technique is highly sensitive to changes in diffusion, which allows to indirectly infer about 
biological tissues’ micro- and macro- structure and tissue orientation. 
 
 
Figure 2.8 From diffusion image to tensor. Note that we only need to apply the gradient in six different directions to generate 
a 3 x 3 matrix, because #KL = #LK, #KM = #MK	and #LM = #ML - adapted from [56].  
 
Diffusion tensor metrics 
From the diagonalization of the diffusion tensor, three orthogonal eigenvectors (;NOOO⃗ , ;+OOO⃗ , ;4OOO⃗ ) and three 
positive eigenvalues (RN, R+, R4) are obtained [53] (Figure 2.9). The eigenvectors reflect the diffusion 
direction (for instance, ;NOOO⃗  is the major eigenvector which points in the direction of fastest diffusion), 
whereas the rotationally invariant eigenvalues reflect the length of diffusion. RN, also called the axial 
diffusivity (AD), is the principal eigenvalue since it reflects the magnitude of greatest diffusion 
(Equation 2.4). The second and third eigenvalues (R+ and R4, respectively) can be averaged to obtain 
the radial diffusivity (RD), the contribution of diffusion in the transverse plane (Equation 2.5). Other 
combinations of eigenvalues can be performed to calculate useful metrics of diffusion, including the 
mean diffusivity (MD) and fractional anisotropy (FA). MD can be calculated as the mean of the three 
eigenvalues, reflecting the total amount of diffusion for each voxel (Equation 2.6). The most widely 
used measure for quantifying the degree of anisotropy in each voxel, FA [57], is able to characterize the 
microstructural integrity of biological tissues (Equation 2.7). FA ranges from 0 and 1, meaning maximal 
isotropic diffusion and maximal anisotropic diffusion, respectively. In other words, FA gives how far 
the tensor is from a sphere. Color-coded FA maps [58] can be generated by assigning a color accordingly 
to the principal diffusion direction (red to left-right, green to anterior-posterior, and blue to superior-
inferior). By combining the directional information of individual voxels main tracts are reconstructed.  
 
 
 
Figure 2.9 Different shapes of the diffusion tensor, and its relationship with diffusion 
eigenvalues - adapted from [56].  
 
 
 
 
  
14 
A#	 = 	 R1          (2.4) 
 S# = 	 R2UR3+           (2.5) 
 V#	 = 	 R1UR2UR34 	          (2.6) 
 WA	 = 	XN+	 Y(	R13	R2)\U(R13	R3)\U(	R23	R3)\XR1\UR2\UR3\ 	          (2.7) 
 
Other quantitative metrics can be explored [18] to obtain a novel biophysical characteristics of the tissue 
being studied, namely linear anisotropy (B]), planar anisotropy (B^), spherical anisotropy (B_), 
attenuation coefficient (AC) map and relative anisotropy (RA). However, it is important to note that all 
DTI metrics consist of an indirect approximation of tissue microstructure and the investigator should 
have precaution regarding its interpretation [59]. 
 
One of the biggest challenges in DTI is to choose an intuitive way of representing the diffusion tensor 
[14]. One can either represent the tensor information using one or four scalars, respectively, if we are 
looking at a single metric or color-coded maps (three elements for RGB and one for brightness). A more 
visual way of representing the diffusion tensor information is through an ellipsoid [57], an iso-surface 
of Gaussian diffusion probability that is created based on the eigenvectors and eigenvalues of diffusion 
[60]. The ellipsoid reflects the ADC in each direction at a specific time. In isotropic movement, the 
ellipsoid is a sphere because the ADC has the same value in all directions. On the other hand, the 
ellipsoid in anisotropic movement has a prolate (elongated) shape, reflecting the increase ADC along 
the direction where there is no constraint for the movement (Figure 2.10). Ellipsoids are the most 
common example of various small 3D objects that portray the diffusion tensor, also called glyphs [53]. 
Glyphs describe the tensor by its size, shape, location, and color [14]. However, glyphs lack a global 
characterization of the tensor, which can be achieved using a method named tractography. 
 
 
Figure 2.10 Diffusion ellipsoids - adapted from [53]. 
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2.2.2 Tractography 
Tractography is an advanced post-processing step that uses the diffusion tensor information to visualize 
streamlines in 3D, and consequently, extract some of its properties, namely number, density, thickness 
and directionality. Its main principle is based, firstly in the computation of the diffusion tensor at a 
particular voxel, and then, in following a streamline in 3D from voxel to voxel. The step of defining the 
initialization voxels from which the streamline will be propagated, is called seeding [14]. The 
initialization voxels can be defined manually by drawing a region of interest (ROI) in the DTI image. 
Since the diffusion image has limited spatial resolution [49], it can be useful to draw the ROIs in the 
anatomical or functional image to restrict the fiber tracking to a particular area of interest, which can be 
called the process of “virtual dissection”. Also, ROIs can be defined based on automated methods [61]. 
The second step of tractography is propagation, which can be done using different types of algorithms, 
classified as deterministic or probabilistic [53] (Figure 2.11). Deterministic, or streamline tractography, 
uses computational methods to generate discrete curves or trajectories, such as Euler’s method, second 
or fourth order Runge-Kutta, and fiber assignment by continuous tracking (FACT). In FACT [62], the 
user defines the initiation voxels and the termination based on well-defined stopping criteria, namely 
the maximum turning angle and the minimum FA. In this algorithm, at the edge of the voxel the tracking 
follows the direction of the main eigenvector of the next voxel, and so on, until the stopping criteria is 
reached. For determinist algorithms different interpolation methods exist, including tri-linear and 
Runge-Kutta of second or fourth order. In probabilistic algorithms, it is taken into account the expected 
uncertainty in the tracking, due to different factors (noise, patient movement distortions or uncertainty 
in the orientation of the diffusion ellipsoid). The choice of the method depends on the application [14]. 
If the goal is to define the most likely path of a fiber, one should use a determinist approach. On the 
other hand, if the goal is to observe all the possible paths and the likelihood of a voxel being part of a 
fiber, probabilistic tracking is the preferred choice. In order to evaluate tractography pipelines, an online 
system has been developed which tests the output effect of different components (acquisition 
parameters, modelling techniques, tractography parameters and algorithms) [63].  
 
Figure 2.11 Schematic comparison between two tractography propagating methods, a 
deterministic (A) and a probabilistic (B) algorithms starting from the seed point (green) - adapted 
from [64]. 
A limitation of tractography can be the unfeasibility of defining if the movement along the fiber is in 
the antegrade or retrograde direction [47]. For probabilistic methods, its accuracy is still limited by the 
diffusion tensor information and the method of constructing the probability density function. 
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2.2.3 Diffusion tensor imaging workflow 
 
Currently, there exist several software packages that are involved in different stages of DTI processing 
and analysis [14]. An adequate choice of software is mainly centered in the steps of the diffusion pipeline 
that one would like to follow, the study application (brain or other organs) and the tractography 
algorithm behind it. For instance, DSIStudio [4] is a tractography software that is applied on surgical 
planning and histology studies. It is used mainly for tensor estimation, ROI analysis and tractography. 
The tractography algorithm that it uses is FACT, a common DTI deterministic algorithm present in most 
DTI software packages. In software packages like MRtrix [65], Dipy [66] and DSIStudio, instead of 
using a voxel-based index - like FA or generalized fractional anisotropy (GFA) -, an orientation 
distribution function (ODF)-based index is used for defining fiber tracking termination. Particularly, it 
utilizes the ODF-based index quantitative anisotropy (QA) that allows a reduction of partial volume 
effects and noisy fibers, improving overall tracking accuracy [4]. In a 2015 international tractography 
challenge, this software has been shown as the most accurate in mapping the human connectome by 
diffusion tractography, comparing with other 96 submitted methods [67]. Tractometer was the tool used 
to quantitatively compare each method with the ground-truth bundles, created from multiple whole-
brain global tractography maps. 
The DTI pipeline can involve different steps, shown in Figure 2.12, such as the definition of an 
acquisition protocol taking into account the application field, artifact handling, data quality control, the 
choice of a reconstruction algorithm, visualization and quantitative analysis on the extracted metrics.  
 
Figure 2.12 Main important steps of the DTI workflow - adapted from [14]. 
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2.2.4 Motion distortion and eddy currents correction 
 
DTI images suffer from artifacts, that can be originated by different sources, including the hardware of 
the system that applies the gradient, the sequence itself, the acquisition strategy and the subject motion 
during the MR acquisition [14]. Particularly, subject motion results in a spatial shift of the images. 
Additionally, since the gradients are applied on and off for a longer time in DTI acquisitions, eddy 
current distortions can arise due to perturbations in the local magnetic field. These perturbations 
originate inductions in the conducting surfaces of the MRI scanner, which results in geometric 
distortions – contraction and/or shift and shear of the image volumes. These artifacts can preclude a 
reliable tensor estimation, and consequently affect the information that is obtained from diffusion maps, 
resulting in the generation of erroneous fiber tracts. 
  
In order to correct for artifacts caused by subject motion, it is possible to reduce the scan time by using 
an echo planar imaging (EPI) sequence, for instance. On the other hand, this sequence can be more 
sensitive to other artifacts [68], namely, eddy current distortions, field inhomogeneities at B0 (that are 
more pronounced at higher fields), image blurring and limited resolution from T2. For instance, B0 
distortion originates both spatial shifts, geometrical distortions and intensity variation. In order to correct 
EPI distortions, when using a 3T field or higher, it is important to do parallel imaging with, for example, 
sensitivity encoding (SENSE). This is possible by the use of phase-array coils that decrease readout 
times by reducing echo train and increasing signal-to-noise ratio (SNR). Total readout time (in seconds) 
can be defined as the time taken to acquire all phase encode steps required to cover the k-space, that is 
calculated by Equation 2.8 for a Philips scanner [69]. Overall, shorter readout times make the sequence 
less sensitive to artifacts.  
 `a.bc	*;bdae.	.Cf;	(Cg	h) = iefD;*	aj	;kℎa;h	 × 		mjj;k.Cn;	;kℎa	hobkCgp			(2.8)		
where, 
 mjj;k.Cn;	;kℎa	hobkCgp =	 qrstu	vrs	_w9vs	(^tu	^9Kt])qrstu	vrs	_w9vs	(9x	yM)	×	z{w|	sur9x	]tx}sw	×	={{t]turs9|x	vr{s|u	(~z~z)	 (2.9) 
  
When the acquisition strategies – also called prospective (real time) correction – are not enough to deal 
with artifacts, preprocessing – also called retrospective correction –, should be applied to DTI data. 
Essentially, the correction of motion and eddy current distortions can be done by using tools that do 
volume registrations, respectively, rigid body and affine registrations to the diffusion b0. Although its 
advantages, it is important to note that retrospective correction depends on the effects of subject motion 
and on the utilization of non-linear approaches, that can assume specific model assumptions, that can 
introduce non-physiologic factors into the images [68]. 
 
One of the most known tools for retrospective correction is the FMRIB’s software library from FSL 
[70], that includes both “eddy” and “topup” packages. “eddy” from FSL is used to correct both for eddy 
current distortions and patient motion. So that “eddy” can distinguish individual variations that come 
from the diffusion signal, from those that come from eddy and motion distortions, the DTI data has to 
follow two main assumptions. Firstly, that there is a sufficient number of diffusion encoding directions 
that span the entire diffusion sphere (with a higher b-value needing of a larger number of diffusion 
directions), and secondly, that two acquisitions in opposing phase-encoding (PE) directions, such as 
AP/PA (anterior-posterior and vice-versa) or RL/LR (right-left and vice-versa), are obtained [71]. On 
the other hand, “topup” is used to estimate the susceptibility induced distortions, that causes geometrical 
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distortions, due to the existence of tissues with different magnetic susceptibilities. The susceptibility 
induced field can be calculated using the two acquisitions with opposing PE directions. The calculated 
field is the one that, when applied to the two volumes with opposing directions, maximizes the similarity 
between the unwarped images [72]. That way, “topup” results can be used as an input for “eddy”, to 
correct for susceptibility induced distortions priory to eddy currents and subject motion correction. 
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3 STATE-OF-THE-ART 
 
Diffusion-weighted imaging (DWI) is a non-invasive MRI-based technique that was firstly introduced 
in 1985 [73]. It has been considered a promising in vivo tool for accessing the microstructure and 
pathophysiology of tissues. While DWI refers to the contrast of the acquired images, diffusion tensor 
imaging (DTI) is a type modeling of the DWI datasets [14]. DTI has been widely used in clinical 
practice, with acknowledged success mainly in brain studies. Among the most important applications of 
DTI are the study of white-matter abnormalities, namely in stroke and brain tumors, neurodegenerative 
disorders, neuropsychiatric disorders, mild cognitive impairment, development disorders, movement 
disorders and neurogenetic developmental disorders [14]. Also, a few studies have identified white-
matter changes during neurodevelopment and ageing [74]. With a growing ageing population, also more 
brain age-related disorders arise, which makes the investigation of age-related differences in white 
matter a crucial task. In particular, a study [75] has shown that ageing affects the integrity of some white 
matter tracts. Other studies include the understanding of brain connectivity, where efforts have been 
made to map the human connectome in combination with other imaging modalities [76]. In addition, 
DTI has been in growing expansion in the field of imaging genetics [77] investigating the interplay 
between genes, brain and behavior. In the future of brain DTI, this technique is expected to be valuable 
in disease treatment planning, detection of preclinical markers, and microstructural abnormalities [14]. 
Diffusion tensor imaging beyond the brain 
 
DTI applications also extend to other tissues and organs beyond the brain, namely the spinal cord [78], 
[79], peripheral nerves [80], [81], heart [16], breast [82], [83] and skeletal muscle [81], [84]. Despite 
the feasibility has been proven for DTI in a growing amount of applications, its impact in radiological 
practice is still limited. Particularly, a study regarding DTI of the skeletal muscle has investigated age-
related changes in the medial and lateral gastrocnemius, muscles of the lower leg [85]. They have found 
an increase in FA with age, although not statistically significant, and a significant fiber length decrease. 
The former can be explained by a decrease in fiber diameter with a consequent decrease in the tertiary 
eigenvalue (R4), that characterizes muscular atrophy with ageing.   
 
Technical advances have enabled the extension of DTI applications to the abdominal and pelvic organs 
[86] including the liver [87], pancreas [88], kidneys [15], [89] (Figure 3.1), uterus [90] and prostate [17], 
[91], [92]. DTI of these organs has been particularly useful in the evaluation of disease states in organs 
with highly directionally arranged structures and in the diagnosis of focal lesions. Although further 
investigations are needed to improve some technical aspects, DTI should be integrated in the multimodal 
clinical practice for these organs.  
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Figure 3.1 DTI of a mouse kidney, created using DSI Studio by Nian Wang, Center for In Vivo Microscopy (Directed by Dr. 
G. Allan Johnson), Duke University, U.S – adapted from the BMC ‘Research in progress’ 2018 competition results [93]. 
  
 
Normal prostate diffusion tensor imaging  
 
Although previous studies [94], [95] have thoroughly investigated the diffusion of the prostate using 
DWI, a quantitative study of diffusion anisotropy was not possible to be performed, since it could only 
be achieved by measuring the diffusion tensor. The first study to prove the feasibility of in vivo prostate 
DTI was published in 2004 [17]. DTI images of six healthy subjects (mean age of 29 years old) were 
acquired on a 1.5 T system using a single-shot diffusion-weighted echo-planar imaging sequence applied 
in 7 directions. This sequence allowed to overcome aspects that were limiting its use in the abdomen, 
including poor SNR and movement artifacts [96]. This study was useful to establish the best acquisition 
and processing techniques for prostate DTI data, including evaluation of two acquisition modes - low-
bandwidth with the receiver coil in phased-array mode comparing with high-bandwidth with the receiver 
coil converted to linear mode -, the choice of the number of diffusion-encoding directions, the use of a 
linear array surface coil comparing with a rectal coil, and the optimization steps to minimize distortions 
caused by eddy currents. Regarding the acquisition mode, the low-bandwidth mode presented a higher 
SNR, but also more geometrical image distortions. These distortions could potentially be reduced by the 
use of postprocessing methods of correction that require an increased acquisition time for its 
implementation. Since this increased acquisition time is incompatible with the absence of increased 
patient’s motion, the choice of the high-bandwidth with the receiver phased-array coil converted to 
linear mode turned out to be the best option. In addition, the lower SNR of this mode can be compensated 
by the acquisition of multiple averages. Using a surface coil as receiver was a better option than the 
endorectal coil, that originated field inhomogeneities artifacts despite its higher SNR. Regarding the 
choice of the number of diffusion-encoding directions, in this study [17] they have used 7 
directions, using a combination of tetrahedral/orthogonal sensitization. Although the acquisition of a 
large number of gradient directions has shown to yield good results for the brain DTI  - for instance, 61 
directions originated more fibers than 6 directions [97] -, it is related with a longer imaging time, which 
is incompatible with the most of body organs due to subjects’ motion. In order to establish a consensus 
on the number of diffusion-encoding directions for prostate DTI, Kim et al. 2012 [91] have prospectively 
analyzed DTI images at 3T from twelve healthy subjects subdivided into three groups with a different 
number of non-collinear directions – 6, 15 and 32 (with the respective acquisition times of 2 min 54 s, 
6 min 51 s and 7 min 17 s). They have shown that, although the mean FA in the PZ was statistically 
significant different among the three groups, significant differences were not found in the SNR of these 
groups. So, they have concluded that the number of diffusion-encoding directions tested had no 
significant effect on overall imaging quality. 
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The study from Sinha and Sinha 2004 [17] was also useful in establishing normative diffusion tensor 
values for the PZ and the central gland (CG) of the prostate, including the eigenvalues, mean eigenvalue, 
MD, FA and anisotropy measure (AÄ), for each patient. The latter does not require diagonalization, 
which could result in a higher accuracy in measuring diffusion. However, the use of AÄ in this study 
had no particular advantage comparing with FA. The MD found for the PZ (1.95 ± 0.08 ×	1034	mm+/s) was higher than the MD for the CG (1.53 ± 0.34	 ×	1034	mm+/s), which can be explained due to 
tissues’ microstructure. Whereas, the former is composed mostly by loosely fibers, the latter is 
comprised by compact and well-oriented fibers. The PZ and CG presented similar values of FA (0.46 ±0.04 and 0.40 ± 0.08, respectively), but these were slightly higher for PZ, which is non-compliant to 
CG’s greater structural organization. Also, they have obtained several diffusivity maps, including the 
tensor images in each direction, eigenvalues’ maps, FA maps, color anisotropy maps and color maps of 
the fibers’ directions. The diffusion in the prostate was found to be described by a prolate model 
(RN	>	R+	=	R4) being characterized as anisotropic diffusion, that occurs mostly in the superior-inferior 
direction.  
Overall, this study was an indicator of the possibility of using the diffusion tensor information and 
derived parameters to identify microstructural changes of the prostate, before its occurrence could be 
detected in larger scale. 
More recently, a study [92] has focused on establishing normative acquisition parameters (including b-
value, slice thickness, matrix and FOV values) for prostate DTI on a 3T MRI system, so that there is a 
consensus on normative FA and MD values for the PZ and the CG of the prostate in healthy subjects. 
The MD in the two regions confirmed the pattern identified by Sinha and Sinha 2004 [17]. However, 
the FA found followed an opposite pattern comparing with that study, meaning that, the FA on the CG 
(0.26 ± 0.06) was higher than the FA on the PZ (0.16 ± 0.03), which is concomitant with the 
microstructural organization of these two regions. Additionally, tractography findings were mostly 
color-coded in blue (Figure 3.2), which has confirmed the expected superior-inferior orientation of the 
prostate gland fibers. Also, darker blue on the CG has shown an increased anisotropic diffusion in this 
region, which is compatible with the increased FA. 
 
 
Figure 3.2 Tractography of the prostate gland, with a dominancy of 
blue tracts (superior-inferior orientation), especially in the CG – 
adapted from [92]. 
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Prostate diffusion tensor imaging both in cancer and benign prostatic hyperplasia, and 
characterization of age-related changes 
 
Many studies [95], [98]–[100] have extended the use of prostate DTI to report the results on PC, in order 
to evaluate if it was possible to use diffusion parameters to differentiate between benign prostate tissue 
and cancer. In a recent paper by [18], they have found that eighteen DTI metrics varied considerably 
between normal and cancer patients and even found a higher fiber tract density in cancer patients. This 
study has proven that prostate DTI can provide valuable quantitative metrics in the identification and 
characterization of PC. 
 
Since the age differences may affect DTI parameters, the age effect should be taken into account to 
allow an early diagnosis of PC using these DTI metrics. A few studies have focused on using DTI for 
evaluating age-related changes in normal prostate. Whereas in [101] they have found lower FA and 
higher MD with increased age in the PZ, in [102] they reported higher MD with increased age, in both 
regions (PZ and CZ). Overall, a decreased fiber integrity in the prostate was related with increasing age. 
 
Furthermore, it is possible to use DTI to differentiate between malignant and benign prostate conditions, 
as proven by [103]. They have discovered that patients with BPH present significantly higher MD and 
lower FA, comparing with central gland cancers, suggesting that central gland tumors are more 
organized and oriented microstructures than hyperplasia foci. 
  
Diffusion tensor imaging of the periprostatic neurovascular fibers  
 
Several studies using DTI of the prostate gland, have focused on PNFs mapping by tractography [104] 
[105] or PNFs’ changes visualization before and after RP [106]. The latter has observed a statistically 
significant decrease in the number of fibers using non-nerve sparing techniques. A recent study [7] even 
found a statistically significant positive correlation in the ratio between the number of PNFs, before and 
after RP, and the ratio between the questionnaire scores for erectile function, also between these two 
time points. On the other hand, no correlations were found between the degree of PNFs sparing and 
postoperative urinary incontinence, possibly due to the influence of other factors (including the urethral 
sphincter damage). Another study [107] has supported the previous findings, with no significant 
correlations between PNFs’ DTI metrics (tract number, length and FA) and the ICIQ-SF test scores on 
urinary incontinence 6-months pos-surgically. In Paola et al. 2018 [7] the authors found that, after RP, 
there was a decrease in FA for PNFs at prostate mid gland, which suggests a loss of orientation and 
arrangement of the fibers. Also, this decrease in FA was accompanied by an increase in MD values, 
meaning higher water molecules diffusion.  
In addition, a few studies have investigated technical aspects of image acquisition and processing on 
PNFs tractography. A study [108] has evaluated the influence of different FA threshold values (0.20, 
0.05 and 0.01) on PNFs fiber tracking, regarding the tract number and length. They have observed that 
measured parameters significantly depended on FA thresholds, more specifically, for the lower FA 
threshold analyzed an increase in DTI tract number was observed. However, they have shown that it 
should be taken into consideration that DTI tracts may not really represent nerve tracts. So, although 
PNFs tractography has been successfully demonstrated in many studies, its use is still not widely 
accepted, and caution must be taken when making conclusions. Moreover, a study [109] has compared 
two methods, DTI using local look technique and DTI using single-shot spin-echo EPI with SENSE, in 
terms of number of fibers, FA and distortion evaluation by the dice similarity coefficient calculation. 
They have found that, although no significant differences were found regarding image distortions, the 
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local look technique has shown to originate an increase in the number of fibers detected and an absence 
of imaging artifacts on FA maps. Overall, this technique represented an increase in visualization 
performance, allowing a more accurate depiction of the PNFs, which may help guide nerve-
sparing RALRP in order to improve potency outcomes. 
 
Diffusion tensor imaging of the urethral sphincter complex  
 
Whereas studying the PNFs can open a window into the understanding of postoperative erectile 
dysfunction, studying the urethral sphincter is of major importance to learn the causes of urinary 
incontinence following RP. For more than 150 years, the preferred method to understand the sphincter 
complex structure has been the cadaveric dissection of normal adult pelvis [24], which has limitations 
because of the inaccessibility of the sphincters in the deep pelvis, connective tissue infiltration and 
structure’s small size [110]. Since its precise anatomy has not yet been established, other techniques 
have been employed, including, sphincter electromyography [8], micro computed tomography [9], 
evacuation proctography [10], elastography using ultrasound [11], transurethral ultrasound [12] or 
magnetic resonance imaging (MRI) [13]. In respect to ultrasound to study skeletal muscle, it has some 
limitations [85], like the fact that it only studies the muscle architecture two-dimensionally, it is 
applicable to a small area of the organ of interest, and not completely accurate to study muscles that are 
located deeper in the body, which is the case of the male urethral sphincters. These techniques have 
allowed a better understanding of the sphincters' anatomy and its correlation with dysfunction and 
ageing. Regarding the latter, morphological and functional studies have already shown that ageing 
induces degenerative changes in the urethral rhabdosphincter. A functional study [2] has evaluated 
several parameters of the function to study how this structure behaves with age and has found that most 
of the rhabdosphincter parameters - sphincter length, maximum urethral closure pressure and urethral 
closure pressure during voluntary contraction - significantly decreased with age. Since the age 
degeneration mechanism occurs mainly due to apoptosis of striated muscle fibers [111] - with a 
progressively decrease of striated muscle cell density (Figure 3.3), concomitant with a replacement by 
fat cells and connective tissue -, it is expected a macroscopically alteration of the rhabdosphincter with 
increasing age, that may explain the higher incidence of urinary incontinence with age. In order to 
investigate individual morphological variations in the distal sphincter with ageing, a histological study 
on 25 elderly Japanese men [25], has found that with ageing the sphincteric action is rather weak or 
incomplete. This probably suggests that the elderly men maintain continence by a different mechanism 
than the younger men, that involves the backward and upward retraction of the urethra. 
 
Figure 3.3 Evolution on the density of striated muscle cells of rhabdosphincter with age, both in males and females – adapted 
from [111]. 
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More recently, in order to study in vivo and non-invasively the directionality of the internal 
microstructure of the sphincters, DTI has emerged as a promising tool that can bring new insights into 
the urethral sphincter anatomy and function with gender, disease and ageing.  
One study [19] has been able to use DTI to understand the anatomy of the normal pelvic floor in five 
female nulliparous subjects (mean age of 28 ± 3 years old), in order to study pelvic floor dysfunction. 
In this, they have performed a diffusion-weighted spin-echo planar imaging (SP-EPI) sequence for DTI 
and a T2-TSE multiplanar sequence to use as anatomical reference. The three eigenvalues (RN, R+, R4), 
FA and MD, obtained for each one of the subjects, were significantly different between structures of the 
pelvis, and tractography resulted in a satisfactory representation of these structures including the urethral 
sphincter complex (Figure 3.4). 
 
 
Figure 3.4 Transverse FA map on the inferior pelvic floor of a 31 year female subject (a) – depicting the external obturator 
muscle (OE) and the puborectal sling (PS)-, and tractography of the female urethral sphincter fibers in an antero-lateral (b) 
and cranial view (c) – adapted from [19]. 
 
However, they have not been able to differentiate between the proximal and distal sphincters. Other 
limitations of this study were the small sample size and the homogeneity of the patients’ dataset in terms 
of age and gender, which hinders the establishment of objective reference values for the diffusion in 
pelvic floor structures. Furthermore, this technique can be user-dependent and time-consuming - 
because a manual selection of ROIs has to be performed for the seeding of fibers. In future studies, using 
a larger and more heterogeneous cohort, assessing reproducibility of the technique (inter- or intra-
observer variability) and using automated methods for tractography might overcome the reported 
limitations.  
 
Although this study proves the feasibility of DTI with tractography of the pelvic floor in women, the 
first one [3] to prove it for the male urethral sphincter complex has only been published in 2018 by two 
of the same authors who firstly showed the feasibility of prostate DTI [17]. They have analyzed eleven 
healthy young subjects (mean age of 25.4 years old) that were scanned at a 3T MRI system from General 
Electrics with high-resolution proton-density scans for accurate localization of middle slices and with 
an additional diffusion-weighted SP-EPI sequence for DTI (32 gradient directions and b-value of 400 s/mm+). After data processing, diffusion metrics have been extracted using DTIStudio for each one of 
these participants - including FA, the three eigenvalues (RN, R+, 	R4), MD and RD. Reproducibility 
indices, including the coefficient of variation and the repeatability coefficient, were calculated for 
obtained DTI metrics. In addition, fiber tracking was performed using DTITools with the FACT 
algorithm. They have been able to clearly differentiate between the two sphincters, namely the proximal 
or lisso-sphincter and the distal or rhabdosphincter, as well as the longitudinal fiber in a superior-inferior 
direction (Figure 3.5). The proximal sphincter was the region that reported the higher FA and lower	R4, 
significantly different from the metrics extracted for the other muscles. The repeatability coefficient 
values obtained represent a 15-20 % change from the mean values, allowing the detection of regional 
differences in that range which is sufficient to distinguish between normal and damaged muscle tissue. 
The findings for FA and R4 suggest a tight packing of fibers in the proximal sphincter, which is required 
for the more demanding task of maintaining continence at rest. Differences in diffusion metrics between 
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regions are thought to be correlated with differences in the microarchitecture of the sphincters’ tissue, 
in terms of fibers’ density and length. This is a starting point to study its correlation with function, 
namely with the urethral closure function and urinary incontinence following RP or other prostate 
surgical procedures. In particular, this technique can be applied to monitor PC patients after lisso-
sphincter removal. Also, future studies can use this work as a reference to investigate gender-, disease- 
and age-related differences in the sphincters. The current study still has its limitations that should be 
taken into account in future investigations, including the small sample size, the low SNR of muscle 
because of the large radio-frequency coil used and the corruption by partial volume effects due to the 
small size of the sphincters. 
 
 
Figure 3.5 Tractography of the male urethral proximal and distal sphincters, as well as the membranous urethra (in green 
are depicted the ROIs drawn for the tracking, positioned at the level of the sphincters), for three healthy subjects – adapted 
from [3]. 
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4 MATERIALS AND METHODS 
 
4.1 Ethics Committee approval 
 
This study was carried out under the approval of the CCU’s Ethics Committee, involving the acquisition 
of a DTI sequence in addition to the standard mpMRI already performed at this institution. Participants 
were told that this additional sequence would not translate in different preparation or risks comparing 
to the standard MRI protocol, and will increase the scanning time by no more than 5 minutes.  
4.2 Study dataset 
 
All male subjects that came to the Radiology Department at CCU, between January 2019 and July 2019, 
to perform a prostatic, abdominal-pelvic or pelvic MRI were included in this prospective study.  
For the exclusion criteria, apart from those typical of MRI scans, such as claustrophobia, implanted 
medical devices and severe imaging artifacts, being a PC patient previously submitted to any type of 
treatment for this condition – including radiotherapy, brachytherapy (Figure 4.1) and surgery (Figure 
4.2) – was considered as an exclusion criteria. 
  
Figure 4.1 Representation of a 70 years old subject submitted to brachytherapy to treat PC, reason to be excluded from the 
study. The radioactive seeds implanted on the prostate can be seen on the anatomical T2-weighted image (marked by yellow 
arrows), both an axial (a1) and sagittal views (a2). The presence of these seeds causes imaging artifacts on the DWI with a 
b-value of a 1500 s/mm2 (a3) and on the ADC map (a4). 
 
(a2) 
(a3) (a4) 
(a1) 
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Figure 4.2 Representation of a 70 years old subject submitted to a RP to treat PC, reason to be excluded from the study. The 
absence of the prostate can be identified on the anatomical T2-weighted image, both an axial (a1) and sagittal views (a2), a 
DWI with a b-value of a 1500 s/mm2 (a3), and an ADC (a4). The level at which the prostate is missing is marked in blue. 
A total of 118 subjects were scanned during this time period. However, 23 subjects had to be excluded 
from the subsequent analysis because of the stablished exclusion criteria: 9 of them had no prostate due 
to surgery, 1 was a cancer patient treated with brachytherapy, 8 were cancer patients treated with 
external radiotherapy, and 1 was eliminated due to poor image quality - this patient had a hip prothesis 
which originated severe imaging artifacts. Also, data from 4 of the 5 subjects used for sequence 
parameters optimization proposes were considered as unsuited for the subsequent analysis, because of 
poor image resolution.  
In the end, a dataset of 95 male subjects was used for data processing and analysis. For the subgroup of 
the 69 subjects who presented a biopsy-proven diagnosis, these were divided into 3 main groups: 45 
patients diagnosed with PC, 14 patients diagnosed with BPH and 10 subjects without any diagnosed 
prostate condition, considered as the healthy controls (HC). From the PC group, 14 subjects were 
labelled as TransDouglas, representing a specific population that performed prostate DTI prior to being 
submitted to a new surgical technique of RALRP in the Da Vinci Xi Robotic System at the CCU, for 
treatment of diagnosed locally advanced PC. 
4.3 Clinical variables  
For each subject scanned in this study, a set of clinical variables were collected using the Glintt medical 
records’ system installed on a dedicated workstation at the CCU Radiology Department. These variables 
included age, body mass index (BMI), latest PSA levels in ng/mL – representing the PSA before the 
MR exam –, prostate volume (PV) in cm3, and the clinical diagnosis and treatment (if applicable). 
In particular, for the patients in the PC group, Gleason score from biopsy, tumor location, index lesion 
(in mm) and PI-RADS score were also collected. Also, for TransDouglas patients’ additional parameters 
were collected, including the following preoperative parameters: membranous urethral length (MUL), 
urethral wall thickness (UWT), levator ani muscle (LAM) thickness, all measured in mm. These 
measurements were obtained from the T2 weighted MRI images for each patient, using the locations 
proposed by Robles et al. [112], using the 2D Viewer in Horos v3.3.5. It is important to note that these 
(a2) 
(a3) (a4) 
(a1) 
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measurements were validated by a radiologist with experience in prostatic MRI. The urethral volume 
(UV) was calculated by Equation 2.10, using the measured MUL and UWT. 
áà = 1034â	Váä	 Gãqå+ J+ 	Cg	kf4  (2.10) 
For TransDouglas patients, surgical variables were also collected, including the surgery duration in 
minutes, the type of nerve sparing technique – left, right or bilaterally - and if a lymphadenectomy was 
performed. Also, a set of questionnaire scores  - EPIC (Expanded Prostate Cancer Index Composite), 
IIEF-5 (International Index of Erectile Function), ICIQ-SF (International Consultation on 
Incontinence Questionnaire - Short Form) and IPSS (International Prostate Symptom Score) - were 
obtained in different time points - preoperatively and 24h, 1 week, 2 weeks, 1 month and 2 months after 
surgery - to quantify the PC patients’ quality of life, and the degree of complications both for erectile 
dysfunction and urinary incontinence. 
4.4 Data acquisition 
 
A standard mpMRI was acquired on a 3T MRI scanner (Ingenia, Philips Healthcare, The Netherlands), 
equipped with a 32-channel phased array coil, parallel imaging and multi transmission radio-frequency 
capabilities. This included high resolution T1 and T2 weighted imaging sequences, a diffusion weighted 
imaging (DWI) sequence with b-values of 0 and 1500 s/mm2, and a dynamic contrast enhanced (DCE) 
imaging sequence.  
In addition to the standard protocol, a diffusion tensor imaging (DTI) sequence was acquired using 
single-shot diffusion-weighted echo-planar imaging with parallel SENSE  technique, using a reduction 
factor of 2. This sequence was acquired in the Anterior-Posterior (AP) phase encoding direction using 
the following parameters: 16 diffusion-encoding directions, b-value of 0 (b0) and 600 s/mm2, echo time 
of 68 ms, repetition time of 6600 ms, voxel size of 1.39 ´ 1.39 ´ 3 mm3, matrix size = 68 ´ 65 ´ 40 
mm3, FOV = 200 ´ 200 ´ 120 mm3, number of averages = 1, in-plane resolution = 1.39 mm, slice 
number = 40, slice thickness = 3 mm, gap = 0.3 mm, representing a sequence time of 4 min. Moreover, 
the spin-echo T2-weighted imaging sequence was acquired using a echo time of 125 ms, repetition time 
of 4900 ms, matrix size = 288 ´ 230 ´ 30 mm3, FOV = 200 ´ 200 ´ 90 mm3, number of averages = 2, 
in-plane resolution = 0.31 mm, slice number = 30, slice thickness = 3 mm. The total MRI acquisition 
time was about 30 min. Figure 4.3 represents the DTI acquisition extent, from a few slices below the 
beginning of the bladder to the entry of the penile bulb. 
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Figure 4.3 MRI T2-weighted image of the mid-sagittal slice, labelled with the relevant anatomy, where the orange lines 
define the proximo-distal extent imaged in the DTI acquisition. 
 
Each DTI set was corrected for subject motion using the Philips software, by registering each image 
volume to the b = 0 s/mm2 (b0) using an affine transform. 
 
Moreover, for 17 subjects there has been acquired an additional DTI sequence in the Posterior-Anterior 
(PA) phase-encoding direction using the same parameters, but only for a b-value of 0 s/mm2 (b0). This 
sequence has the propose to be used in the post-processing steps for susceptibility induced distortions’ 
correction.  
Regarding subject’s preparation, they need to be fasting for 4 hours before the examination, and to have 
taken a microlax to clean the bowel. However, no empty bladder requirements are imposed. For DCE 
imaging, the technicians have injected gadolinium contrast agent through an intravenous catheter 
inserted in the left arm, using a dedicated system that allows to control the concentration and flux of the 
contrast agent. A receiver abdominal coil is placed on the subject to amplify the signal.  
The first 5 subjects of these study were used for optimization of the DTI sequence, including the choice 
of the number of gradient directions, the number of slices and an adequate b-value to allow urethral 
sphincters visualization. The extension of the slices was also changed in order to include the complete 
distal sphincter. Table 4.1 represents the combinations of parameters that were acquired in order to set 
the optimal acquisition that represented the best compromise between image resolution and scanning 
duration. 
 
 
 
 
Bladder 
Proximal sphincter 
Prostate 
Distal sphincter 
Membranous urethra 
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Table 4.1 Optimization of DTI acquisition parameters for the first 5 study subjects. The * indicates that this subject had an 
acquisition extension displaced to a more distal region. 
Case number b-value (s/mm2) 
Number of 
directions 
Number of 
slices 
Acquisition 
duration 
(min) 
In-plane 
resolution 
(mm) 
001’ 800 33 25 7.77 1.56 
002’ 800 33 20 6.44 1.56 
001 600 33 30 6.65 1.39 
002 600 33 30 * 6.58 1.39 
003 600 16 40 4.15 1.39 
 
4.5 Data De-identification 
 
Data acquired was searched on OsiriX Data DB medical imaging library and downloaded into Horos 
Data DB medical image viewer. All the tags that reflected information that can either identify the patient 
or the institution and its workers were anonymized, in order to ensure participants’ anonymity and 
protection. Relevant data tags were anonymized using a Python script that uses the de-identification 
(deid) module from pydicom [113]. In total, 27 DICOM tags (Table 4.2) were chosen, most of them 
based on the international standard for de-identification provided by DICOM Supplement 142 Annex 
A1 at [114]. Variables were replaced by strings that take into account its value representation (VR). For 
instance, those represented by a VR called unique identifier (UI), were replaced by a UID, a series of 
numeric components separated by ’.’ that had to be generated for a variable in order to preserve imaging 
information. 
It was created a file that relates information before (Name, ID, patientDir) and after (caseID) the de-
identification, in order to trace back each patient. Regarding clinical variables collected from the Glintt 
medical records’ system, those were saved on a excel file that identifies each patient by its unique 
identifier without any association to subjects’ personal information.  
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Table 4.2 Description on the anonymized DICOM variables, based on its value representation (VR) 
PN  - person name: character string composed of 5 components (family name complex, given name complex, middle name, 
name prefix, name suffix) 
LO – long string: string of 64 characters max 
DA – date (format YYYYMMDD) 
SH – short string: string of 16 characters max 
ST – short text: text that may contain 1 or more paragraphs of 1024 characters max 
AE – application entity: string of characters with 16 bytes max 
UI – unique identifier: character string containing a unique UID (a series of numeric components) 
 
 
 
DICOM 
tag 
Variable name Value 
representation 
(VR) 
Rule for anonymization 
8,0012 InstanceCreationDate DA 1010101 
8,0014 InstanceCreatorUID UI 0.0.00.000000.00.00.0 
8,0018 SOPInstanceUID UI Generated UID 
8,002 StudyDate DA 1010101 
8,0021 SeriesDate DA 1010101 
8,0022 AcquisitionDate DA 1010101 
8,0023 ContentDate DA 1010101 
8,005 AccessionNumber SH 101010 
8,008 InstitutionName LO institutionx 
8,0081 InstitutionAddress ST addressx 
8,009 ReferringPhysicianName PN FAMILYNAME^GIVENNAME 
8,101 StationName SH STATION-0101010101 
8,104 InstitutionalDepartmentName LO deptx 
8,105 PerformingPhysicianName PN FAMILYNAME^GIVENNAME 
8,107 OperatorsName PN FAMILYNAME^GIVENNAME 
10,001 PatientName PN Replaced by “Casexx”, where xx 
stands for the case number. 
10,002 PatientID LO Replaced by “Casexx”, where xx 
stands for the case number. 
10,003 PatientBirthDate DA 1010101 
0020,000d StudyInstanceUID UI 0.0.000.000000.00.0.000000000000
.00000.000000000000000.000.0 
0020,000e SeriesInstanceUID UI 0.0.00.000000.00.00000.0.0.0000.0
000000000000000000 
20,001 StudyID SH 1010101 
20,0052 FrameOfReferenceUID UI 0.0.00.000000.00.00000.0.0.0000.0
000000000000000000 
32,1032 RequestingPhysician PN FAMILYNAME^GIVENNAME 
40,0244 PerformedProcedureStepStartDate DA 1010101 
40,2004 IssueDateOfImagingServiceRequest DA 1010101 
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4.6 Diffusion tensor imaging processing and Tractography  
 
After data de-identification, some steps were performed prior the fitting of a tensor. A schematic 
representation of the diffusion processing pipeline for each subject is represented on Figure 4.4. 
 
 
Figure 4.4 Schematic representation of the DTI processing and analysis pipeline. 
 
Firstly, the data was visualized in Horos for individual image quality inspection, and corrupted images 
were eliminated from the analysis. Then, for the subset of 17 subjects with the b0 acquisition on a PA 
phase-encoding direction, the susceptibility-induced off-resonance field was calculated using “topup” 
that follows the method described in [72] as implemented in FSL [70]. The total readout time needed 
for “topup”, calculated using Equation 2.8 described in the Introduction, was 0.02 s. The schematic 
representations of  “topup” and “eddy” input and output are shown in Figures 4.5 and 4.6, respectively. 
Data corrected for susceptibility-induced distortions was then used as input for eddy currents correction 
using “eddy” from FSL [71]. 
 
For subsequent comparison of eddy currents correction methods, the same subjects were used also for 
motion/eddy currents correction on DSIStudio [4], the software used on the subsequent steps of the DTI 
analysis. The principle behind the correction in DSIStudio is based on the application of an affine 
transform between the diffusion b0 and each diffusion-weighted volume, using image correction as the 
cost function. If similar results are found using the “topup” with “eddy” correction on FSL and the 
motion/eddy currents correction on DSIStudio, the latter has the advantages of involving less post-
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processing steps and do not requiring an additional DTI sequence acquired on an opposite PE direction, 
translating in shorter acquisition times. 
 
 
Figure 4.5 FSL's "topup" schematic representation. 
 
 
Figure 4.6 FSL's "eddy" schematic representation. 
 
 
For each subject, a Python script using the SimpleITK package [115] was built to align the T2 images 
with the b = 0 s/mm2 (b0) of the original DTI. For that, a rigid transform followed by an affine transform 
were applied to the T2 image - set as the moving image -, so that the anatomical location could match 
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the diffusion b0 volume - set as the fixed image, since the diffusion information could not be changed -
to future guidance of ROI placement. 
 
The subsequent steps were repeated for each subject using the original DTI data, the DTI data corrected 
for subject motion during acquisition and, for those subjects with a PA acquisition, also for the eddy 
current corrected data, both using FSL and DSIStudio motion/eddy currents correction.  
 
DSI Studio was the software used for DTI reconstruction and fiber tracking. Firstly, the source (.src) 
file was created from each set of DICOM source images by using batch processing. For the eddy current 
corrected files, the resultant 4D NIFTI file was used as source images to create the .src file, and the 
adequate bvecs file with the rotated vectors was loaded. The .src quality control file was produced for 
image quality inspection. Then, a binary mask was setup to filter background outside the prostate and 
nearby structures (urethra, bladder and rectum) using thresholding, dilation and defragment options on 
DSIStudio. Under this region, DTI reconstruction was made, performing an eigenanalysis on the 
calculated diffusion tensor. From this, a fiber tracking (.fib) file was created that was used for fiber 
tracking. 
 
The deterministic FACT algorithm [4] was used for fiber propagation. For each subject, 3 ROIs were 
drawn to track the proximal sphincter, 3 other ROIs to the distal sphincter and 2 ROIs to the membranous 
urethra. Reconstructions of the tracts were obtained by applying ROI gates following Boolean logic. For 
instance, for both sphincters the first 2 ROIs were AND gates placed symmetrically on both sides of the 
ring, and the third ROI was a Terminative (NOT gate) in a cylindrical shape, made from the subtraction 
of two ROIs that surround the sphincter. On the other hand, for the membranous urethra we have placed 
two AND gates, more specifically, a proximal region near the prostate apex and a more distal one near 
the penile bulb. Whereas the ROIs for the sphincters were drawn on the color-coded maps based on the 
lead eigenvector of the original DTI data, the ROIs for the urethra were drawn on the T2 weighted 
images aligned with the diffusion b0 of the original DTI data. Figure 4.7 shows the ROI placement for 
the proximal and distal sphincter and for the membranous urethra, respectively, the apex and the bulb. 
 
 
 
Figure 4.7 Axial views obtained from DSIStudio showing the ROI placement on the color-coded FA maps for the proximal 
sphincter (a) and distal sphincter (b), and on the T2-weighted image for the apex (c1) and bulb (c2) to track the membranous 
urethra. 
 
For the proximal and distal sphincters, it was used as termination criteria a threshold of 0.15 for FA and 
an angular threshold of 75 degrees. For the membranous urethra, the termination criteria used were the 
same as for the sphincters, except for the angular threshold that was set to 45 degrees. In particular cases, 
where the number of streamlines produced was very low, the FA threshold was decreased to 0.10 or 
0.05 (the latter threshold in fewer cases). Streamlines that had angles above the angular threshold and 
FA values below the FA threshold were excluded from the tracking. In addition, a step size of 0.69 mm 
was chosen, and the fiber trajectories were smoothed by averaging the propagation direction with 9% 
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of the previous direction. Tracts with length shorter than 50 or longer than 200 mm were discarded. A 
total of 30000000 seeds were placed. Table 4.3 shows the fiber tracking parameters set on DSI Studio 
that are common to all structures tracked. 
 
Table 4.3 Fixed fiber tracking parameters for the studied structures of the male urethral complex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After tracking, the streamlines that passed through the ROIs due to the “brute-force” nature of the 
algorithm, but are considered to be spurious and outside of the structure of interest, were eliminated 
manually. For the urethra, the tracts were cut at the levels of the apex and bulb so that it is obtained only 
the membranous portion of the urethra. 
  
Diffusion metrics, namely FA, MD, RD and AD were computed from these tracts for each patient on 
DSI Studio - FA is dimensionless, except for the other metrics that are represented in 10-3 mm2/s. 
Additional metrics, including fiber’s length (in mm), number, volume occupied (in cm3) were collected 
from the tract statistics file. Fiber’s density was calculated for each case, dividing fiber number by 
volume occupied. 
 
 
 
 
 
 
 
 
 
Parameter name Parameter value 
Step size (mm) 0.69 
Smoothing  0.09 
Min length (mm) 50.0 
Max length (mm) 200.0 
Topology-informed pruning 0 
Seed orientation All 
Seed position Subvoxel 
Randomize seeding Off 
Check ending Off 
Direction interpolation Trilinear 
Tracking algorithm  Streamline (Euler) 
Terminate if  30000000 Seeds 
Thread count 4 
Output format trk.gz 
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4.7 Statistical analysis 
 
Statistical analysis was performed in RStudio [116] using R v3.5.0. p-values were reported as 
statistically significant if p < 0.05. The main goal of this analysis was to investigate age-related 
differences on DTI metrics of the urethral sphincters and the membranous urethra. For that, the 
continuous variables patient age and the DTI metrics tract density, tract length, FA, AD, MD and RD, 
for each structure (proximal and distal sphincters, and membranous urethra) were analyzed.  
 
Moreover, for each DTI index (FA, AD, MD and RD) not only the mean value within the structure of 
interest, but also different summary statistics of histogram analysis were extracted and analyzed to 
investigate the distribution of each DTI metric along the tract. Hence, for each patient it was saved a 
text file for each metric along every tract analyzed, using DSIStudio on the command line. Then, the 
function describe from R package 'psych' [117] was used to get the following 14 metrics: standard 
deviation (sd), median, trimmed mean, median absolute deviation (mad), minimum (min), maximum 
(max), range, skewness, kurtosis, standard error (se) and the 5th, 25th, 75th and 95th percentiles. In the 
end, 21 continuous variables were analyzed for each structure. 
 
These variables were subjected to a logarithmic transformation to help data meet the parametric test 
assumptions and were reported as mean ± standard deviation (SD). Additionally, 3 categorical variables 
were included in this study, comprising age group (a factor of 4 levels: 5 for subjects aged 50-59, 6 for 
subjects aged 60-69, 7 for subjects aged 70-79 and 8 for subjects aged 80-89) disease group (a factor of 
3 levels: 0 for HC, 1 for PC patient and 2 for subject with BPH) and cancer status (a factor of 2 levels: 
0 for non-cancer patients, meaning both HC and BPH, and 1 for PC patients).  
 
Motion and Eddy currents corrections on diffusion tensor imaging biomarkers 
 
It was firstly studied whether any of the DTI metrics varied with statistically significance when obtained 
from data with and without both motion and eddy currents corrections. This analysis was performed on 
17 subjects with the PA acquisition, and the DTI metrics evaluated were the ones mentioned above, 
apart from tract number replacing tract density. For that, it was used a t-test to compare each metric 
between the original DTI data and the DTI data corrected for subject motion using the Philips software. 
Normality of each of the groups and homoscedasticity of the pairs that came from normal populations 
were tested using Shapiro-Wilk and F tests, respectively. If these assumptions were not met, the non-
parametric Mann-Whitney test was used. Additionally, a one-way analysis of variance (ANOVA) was 
used to do a comparison between the original DTI data and two different methods of eddy currents 
correction, specifically, FSL “eddy” combined with FSL “topup” and eddy currents correction option 
on DSIStudio. To investigate whether normality and homoscedasticity assumptions were met, Shapiro-
Wilk and Levene’s tests were used, respectively, and residuals were plotted. Otherwise, the equivalent 
non-parametric Kruskal-Wallis test was used.  
 
Relationship between diffusion tensor imaging metrics and age 
 
In order to investigate the hypothesized age influence in each DTI metric, correlations and linear 
regressions were performed between age and the variables of the 95 subjects suited for the analysis. 
Firstly, Pearson and Spearman correlations were calculated between each DTI metric and age. Shapiro-
Wilk tests were performed formerly in order to check the normality of each variable, and if this 
requirement was met, the Pearson correlation was calculated (otherwise, Spearman correlations were 
used).  
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Then, linear regressions were performed, using age as the independent variable (X) and each of the DTI 
metrics as the dependent variable (Y). Assumptions for linear regression were confirmed beforehand, 
namely independence of Y values (known from the design and data collection), linearity of Y with X, 
homogeneity of variances of Y (homoscedasticity) and normality of Y values for each value of X. 
Whereas meeting the first assumption was known from the design and data collection, the last three 
assumptions were confirmed by plotting the residuals of Y.  
 
Moreover, ANOVA tests (or the equivalent non-parametric Kruskal-Wallis tests, for the cases when the 
ANOVA assumptions were not met) were used to investigate whether the DTI metrics varied 
significantly between the four age groups – subjects aged 50-59, 60-69, 70-79 or 80-89. Then, a post-
hoc t-test (or the equivalent non-parametric Mann-Whitney test) was used to identify significant 
differences between age decades.  
 
The effect of a prostate condition in the diffusion tensor imaging metrics 
 
In order to check whether having a PC condition, namely cancer or benign hyperplasia, could influence 
the DTI metrics, the subset of 69 patients with a diagnosis – negative or positive for one of the conditions 
– was studied. ANOVA tests (or the non-parametric Kruskal-Wallis test) were used to investigate 
whether the DTI metrics varied significantly between the three disease groups – HC, PC and BPH. Then, 
a post-hoc t-test (or the equivalent non-parametric Mann-Whitney test) was used to identify significant 
differences between each pair of disease groups. Subsequently, for the 45 patients in the PC group, linear 
regressions were performed between age and each of the DTI metrics.  
 
Then, t-tests were used to compare differences in DTI metrics with cancer status, meaning PC patients 
against non-PC patients (the latter includes both HC and BPH groups described above). For the cases 
where the criteria of normality and homoscedasticity were not met, the equivalent non-parametric Mann-
Whitney test was used. 
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5 RESULTS 
 
5.1 Study dataset descriptive statistics 
 
Subjects’ age distribution 
 
In this section, the main findings of the analysis on the male subjects scanned at CCU, included in the 
study, are described. The total dataset of 95 male subjects analyzed presented a median age of 66 years 
old, ranging from 45 to 89. The age distribution of the total dataset is shown by a density histogram 
divided into bins with a binwidth of 5. (Figure 5.1). One can see that the distribution is almost perfectly 
symmetrical, but slightly negatively skewed. Also, the histogram shows that most subjects of this study 
lie around 65 years old. 
 
 
Figure 5.1 Age distribution of the 95 male study subjects. The normal distribution curve that better fits the data is plotted on 
top of the histogram (in black). 
 
For the subsequent analysis, the total dataset was subdivided by age decades into 4 groups: subjects 
aged 50-59, 60-69, 70-79 and 80-89, respectively with 20, 42, 23 and 9 subjects. No age group between 
40-49 years old was created, since it was only formed by one subject. The subjects’ distribution within 
each age group is depicted in Figure 5.2. 
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Figure 5.2 Subjects’ distribution by age group. The majority of subjects lie in the age group between 60 to 69 years old. 
 
Subjects’ distribution by Disease group and Cancer status  
 
For analyzing subjects by the type of prostate condition they presented, 69 of the total 95 subjects with 
a biopsy confirmed diagnosis were considered. The mean age of the 69 subjects was of 67 years old, 
ranging between 51 to 89. This smaller dataset was subdivided into 3 main groups –PC subjects and 
BPH subjects and HC, respectively with, 45, 13 and 11 subjects each– as described in the Methods. A 
representative subject from each of the disease groups HC and BPH is depicted in Figure 5.3, by means 
of its T2-weighted MRI (axial and sagittal views), DWI with b-value = 1500 s/mm2 and an ADC map. 
The same can be observed for PC subjects, from each one of the tumor location categories – tumor 
located of the PZ, TZ or both (PZ + TZ) – in Figure 5.4. The represented patient with BPH shows an 
enlarged prostate, as clearly seen on the sagittal view of the T2 (Figure 5.3 (b2)). Whereas tumors 
(demarked by yellow arrows in Figure 5.4) appear hyperintense on the DWI b-value = 1500 s/mm2 (the 
sequence where they can be easily detected), they appear hypointense on the T2 and on the ADC map. 
Patient with tumor on the TZ (Figure 5.4 (d)) has a cyst, that appears hyperintense on the T2 (marked 
by an orange arrow). 
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Figure 5.3 Representative 70 years old HC subject with a normal prostate with a volume of 50 cm3 (a) and a 80 years old 
BPH subject with a clearly enlarged prostate volume of 110 cm3 (b). The prostate extension is highlighted in blue. For each 
subject is shown an anatomical T2-weighted image, both on axial (1) and sagittal views (2), a DWI with a b-value of 1500 
s/mm2 (3), and an ADC (4). Images for the HC subject (a) presented some geometrical distortions caused by air in the 
rectum, as marked by orange arrows.  
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Figure 5.4 Representative 60, 75 and 70 years old PC patients with different tumor locations, namely, with a tumor on the 
right middle third and apex of the PZ (c), on the right middle third of the TZ (d) and on the anterior right middle third and 
apex of both PZ and TZ (e). These patients have a Gleason score of 3 + 4, a PIRADS of 5 and an index lesion of, 
respectively, 25, 25 and 20 mm. For each subject is shown an anatomical T2-weighted image, both an axial (1) and sagittal 
views (2), a DWI with a b-value of 1500 s/mm2 (3), and an ADC (4). Tumors are marked by a yellow arrow and a cyst in (d) 
is marked by an orange arrow. 
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Additionally, in order to analyze subjects with a prostate tumor against the ones without tumor, the BPH 
and HC subjects were grouped together in a non-PC group with 24 subjects. Bar plots showing the 
number of subjects lying within each group, respectively, for disease group and cancer status, are shown 
on Figures 5.5 and 5.6. The age distribution of subjects within each group is plotted in Figure 5.7. 
Furthermore, ANOVA testing has shown no statistically significant differences on the patient age of 
diagnosed subjects between disease groups and cancer status groups, respectively, p-values of 0.789 and 
0.565 were found.   
 
 
Figure 5.5 Subjects’ distribution by disease group. Here the PC group is represented by the red bar, the BPH by the orange 
and the HC group by the green. 
 
 
Figure 5.6 Subjects’ distribution by cancer status. Here the PC group is represented by the red bar and the non-PC group is 
represented by the grey bar. 
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Figure 5.7 Age distribution of patients within each disease group, respectively the PC (red), the BPH (in orange) and the HC 
(in green) groups. The latter represents the age distribution of patients for the non-PC group (in grey). 
 
Subjects’ clinical variables 
 
As described in the Methods, a set of clinical variables were collected for each of the subjects. Table 
5.1 summarizes the median, interquartile range (IQR) and the range of values of each of the clinical 
numerical variables collected for the totality of the subjects in this study and for the diagnosed subjects 
within disease groups. ANOVA test results have shown no statistically significant differences on clinical 
variables mean value between disease groups, except for prostate volume. Particularly, a post-hoc 
Wilcoxon test has shown that the difference lied between the HC with the PC groups (p-value = 0.0246) 
and the PC with the BPH groups (p-value = 0.0005). 
 
Table 5.1 Numerical clinical variables for the total dataset (95 subjects) and for each of the individual disease groups of the 
69 diagnosed subjects. Each numerical variable was presented as Median; IQR [min.-max.](N), where IQR stands for 
interquartile range and N for the number of subjects for which that variable information was available. ANOVA (or the non-
parametric Kruskal-Wallis, marked by a *) test p-values for the comparison of each variable between disease groups, is 
shown on the last column. Statistically significant p-values are highlighted in orange. 
Clinical 
variable Total dataset PC patients BPH patients HC subjects 
ANOVA 
(or 
kruskal-
Wallis *) 
p-value 
Patient age 
(years old) 
66; 11 
[45-89] (95) 
67; 14 
[51-87] (45) 
67; 7.0 
[52-80] (13) 
66; 5.5 
[52-89] (11) 
0.789 
Body mass 
index (BMI) 
(kg/m2) 
26.1; 3.62 
[18.3-35.5] 
(90) 
25.9; 3.53 
[21.7-34.3] 
(43) 
26.4; 3.13 
[20.9-33.15] 
(11) 
26.8; 4.17 
[18.3-35.5] 
(11) 
0.782* 
Latest PSA 
(ng/mL) 
6.6; 4.3 
[0.2-94.2] (79) 
7.0; 4.8 
[0.2-94.2] (41) 
6.3; 2.1 
[2.5-9.0] (10) 
6.7; 4.0 
[2.5-20] (9) 
0.445* 
Prostate 
volume 
(PV) (cm3) 
54.0; 26.0 
[14.0-188] 
(93) 
48.5; 18.5 
[14.0-108] 
(44) 
67.0; 32.0 
[40.0-135] (13) 
59.0; 19.5 
[23-92] (11) 0.0005* 
 
  
44 
For patients in the PC group, the categorical variables Gleason score from biopsy, tumor location and 
PI-RADS score are represented by the pie charts depicted in Figure 5.8. The majority of PC patients 
have a tumor located on the PZ (56%) and exhibit a Gleason score of 3+4 (53%). A PIRADS score of 4 
and 5 has a similar representation (33% and 36%, respectively) among PC patients. 
 
Figure 5.8 Pie charts representing the number of PC patients within each category of Gleason score, tumor location and PI-
RADS score. The NA group present in the three categories represents the PC patients for each that information was not 
available. 
 
Still for the PC patients’ group, the distribution of the numerical variable index lesion, meaning the size 
(in mm) of the largest tumor lesion identified in the image, is represented by a histogram in Figure 5.9. 
Most subjects have an index lesion with a size of 10 to 15 mm.  
 
 
Figure 5.9 Tumor index lesion size (maximum length) distribution for PC patients. 
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5.2 Effect of the motion and eddy currents corrections on DTI metrics 
 
In this section, results with and without motion and eddy currents corrections were compared. Firstly, 
let’s start by presenting the results on the evaluation of motion correction on 17 subjects. The results of 
the t-test (or the Mann-Whitney test) for comparing the mean of DTI metrics with and without motion 
corrected is depicted on Table 5.2. One can see that no statistically significant difference was found 
between the means of each DTI metric between motion correction groups.  
 
 
Table 5.2 Statistical test results for motion correction. Non-parametric tests are marked by an *. 
 Variable without 
correction 
Variable with 
correction 
t / W (*) 
statistic p-value 
Proximal 
sphincter 
Tract number Tract number 
registered 1.521 0.140 
Tract length Tract length 
registered 0.810 0.424 
FA FA registered 0.013 0.990 
AD AD registered -0.998 0.326 
MD MD registered 133* 0.708 
RD RD registered 150* 0.865 
Distal sphincter Tract number Tract number 
registered 1.235 0.226 
Tract length Tract length 
registered 147* 0.946 
FA FA registered 0.471 0.641 
AD AD registered -1.755 0.089 
MD MD registered -1.562 0.128 
RD RD registered -1.380 0.177 
Membranous 
urethra 
Tract number Tract number 
registered 150* 0.865 
Tract length Tract length 
registered 0.181 0.858 
FA FA registered 0.747 0.461 
AD AD registered 133* 0.708 
MD MD registered 120* 0.413 
RD RD registered 120* 0.413 
 
 
Secondly, eddy currents correction was evaluated on the same 17 subjects. The results of the ANOVA 
(or the Kruskal-Wallis test) for comparing the mean of DTI metrics between the three groups – no eddy 
currents correction, correction with FSL TOPUP and eddy currents correction option on DSIStudio - is 
depicted on Table 5.3. Once again, no statistically significant differences were found on DTI metrics 
between groups.  
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Table 5.3 Statistical test results for eddy currents correction. Non-parametric tests are marked by an *. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Variable 
without 
correction 
Variable with 
eddy FSL 
correction 
Variable with 
eddy DSI 
Studio 
correction 
F value/ 
Kruskal-
Wallis chi-
squared (*) 
p-value 
Proximal 
sphincter 
Tract number Tract number 
(eddy FSL) 
Tract number 
(eddy DSI) 2.200* 0.333 
Tract length Tract length 
(eddy FSL) 
Tract length 
(eddy DSI) 0.362 0.698 
FA FA (eddy FSL) FA (eddy 
DSI) 0.199 0.820 
AD AD (eddy FSL) AD (eddy 
DSI) 1.211* 0.546 
MD MD (eddy FSL) MD (eddy 
DSI) 0.465 0.793 
RD RD (eddy FSL) RD (eddy 
DSI) 0.405 0.669 
Distal sphincter Tract number Tract number 
(eddy FSL) 
Tract number 
(eddy DSI) 0.712 0.496 
Tract length Tract length 
(eddy FSL) 
Tract length 
(eddy DSI) 1.024* 0.599 
FA FA (eddy FSL) FA (eddy 
DSI) 0.355 0.703 
AD AD (eddy FSL) AD (eddy 
DSI) 0.035 0.965 
MD MD (eddy FSL) MD (eddy 
DSI) 0.221 0.802 
RD RD (eddy FSL) RD (eddy 
DSI) 0.348 0.708 
Membranous 
urethra 
Tract number Tract number 
(eddy FSL) 
Tract number 
(eddy DSI) 0.673* 0.714 
Tract length Tract length 
(eddy FSL) 
Tract length 
(eddy DSI) 1.331* 0.514 
FA FA (eddy FSL) FA (eddy 
DSI) 0.652 0.525 
AD AD (eddy FSL) AD (eddy 
DSI) 1.390* 0.499 
MD MD (eddy FSL) MD (eddy 
DSI) 0.979* 0.613 
RD RD (eddy FSL) RD (eddy 
DSI) 0.806* 0.668 
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5.3 Fiber tracking results on the original diffusion tensor imaging data 
 
Before creating the .fib file with the fiber tracking information, a .src quality control file was obtained 
for each analyzed subject. It was observed that, for every single .src file obtained, there was a b-table 
match and a high neighboring DWI correlation – correlation values ranged from 0.53 and 0.95. 
 
The fiber tracking results for each of the individual structures for the 95 subjects analyzed was 
concordant with the male urethral complex reported microarchitecture. The microstructure of the 
proximal and distal sphincters, as well as the membranous urethra is depicted in Figure 5.10 for one of 
the study subjects arbitrarily chosen. The color map, based on the orientation of the fibers, has the 
following convention – red for left-right (x), green for anterior-posterior (y) and blue for superior-
inferior (z) directions. For the same subject, each of the studied structures of the male urethral complex 
is shown on three different views (axial, sagittal and coronal), and positioned relatively to the acquired 
slices, namely, the T2-weighted images (Figure 5.11). On the anatomical images, one can observe the 
proximal sphincter located between the inferior portion of the bladder (brighter on the image) and the 
base of the prostate. Moreover, the tracked distal sphincter can be seen between the apex of the prostate 
to the penile bulb, surrounding the membranous urethra that has the same extension.  
 
 
Figure 5.10 Fiber tracking results derived from the DTI images of an arbitrarily chosen study subject, a 61 years old PC 
patient with a tumor located on the PZ. This figure shows the microstructure of the proximal and distal sphincters and the 
membranous urethra, color-coded based on the direction of the fibers - red for left-right (x), green for anterior-posterior (y) 
and blue for superior-inferior (z) directions. 
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Figure 5.11 Fiber tracking results overlaid on the T2 maps, for one of the study subjects arbitrarily chosen. From top to 
bottom, respectively, it is represented the proximal sphincter, the distal sphincter and the membranous urethra for this 
subject. From left to right, respectively, each structure of interest is shown on the axial, sagittal and coronal views. 
 
 
For each subject involved in this study, fiber tracking performed on the original DTI data allowed to 
extract a set of DTI metrics – FA, AD, MD, RD, fiber length and fiber density. One subject from each 
age and disease group was arbitrarily chosen to have their sphincters and membranous urethra  
represented through color-coded images for each of the DTI metrics analyzed (FA, AD, MD and RD) – 
Figures 5.12 to 5.17, respectively showing the proximal sphincter, the distal sphincter and the 
membranous urethra by age group and disease group. The color bar, on the right side of the figures, 
encodes the intensity of each DTI metric. Whereas regions of the structures with a higher DTI metrics’ 
intensity (set to the maximum value of that metric among subjects) are represented in red, areas with a 
lower intensity (closer to zero) are represented in blue. In particular, the first row of each figure color-
encodes the anisotropy changes within each structure.  
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Figure 5.12 Color-encoded DTI metrics (from top to bottom, FA, AD, MD and RD) for the proximal sphincter of four study 
subjects representative of each age decade. Red depicts regions with a higher DTI metric value, while blue depicts regions 
with a DTI metric value closer to zero. 
 
 
 
Figure 5.13 Color-encoded DTI metrics (from top to bottom, FA, AD, MD and RD) for the distal sphincter of the same four 
study subjects chosen for Figure 5.12. Red depicts regions with a higher DTI metric value, while blue depicts regions with a 
DTI metric value closer to zero. 
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Figure 5.14 Color-encoded DTI metrics (from top to bottom, FA, AD, MD and RD) for the membranous urethra of the same 
four study subjects chosen for Figure 5.12. Red depicts regions with a higher DTI metric value, while blue depicts regions 
with a DTI metric value closer to zero. 
 
Figure 5.15 Color-encoded DTI metrics (from top to bottom, FA, AD, MD and RD) for the proximal sphincter of three study 
subjects representative of each disease group –HC, PC subjects and BPH subjects. Red depicts regions with a higher DTI 
metric value, while blue depicts regions with a DTI metric value closer to zero. 
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Figure 5.16 Color-encoded DTI metrics (from top to bottom, FA, AD, MD and RD) for the distal sphincter of the same three 
study subjects chosen for Figure 5.15. Red depicts regions with a higher DTI metric value, while blue depicts regions with a 
DTI metric value closer to zero. 
 
Figure 5.17 Color-encoded DTI metrics (from top to bottom, FA, AD, MD and RD) for the membranous urethra of the same 
three study subjects chosen for Figure 5.15. Red depicts regions with a higher DTI metric value, while blue depicts regions 
with a DTI metric value closer to zero. 
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The mean and standard deviation of the DTI metrics for the 95 study subjects, obtained both for the 
proximal and distal sphincters, as well as for the membranous urethra, are summarized in Table 5.4. The 
remaining 14 histogram metrics of each DTI index are shown in the Appendix Table A. 
 
Table 5.4 Mean and standard deviation (mean ± sd) values on the DTI metrics of the 95 male study subjects, for each 
analyzed structure of the urethral complex. Tract density is expressed in tracts/mm3; Tract length in millimeters (mm); 
Diffusivity measures - AD, MD and RD - in 10-3 mm2/s; FA is dimensionless. 
 Proximal sphincter Distal sphincter Membranous urethra 
FA 0.36 ± 0.04 0.32 ± 0.04 0.33 ± 0.05 
AD 2.18 ± 0.18 2.11 ± 0.21 2.13 ± 0.39 
MD 1.59 ± 0.16 1.60 ± 0.19 1.58 ± 0.32 
RD 1.30 ± 0.16 1.35 ± 0.18 1.30 ± 0.29 
Tract density 1.25 ± 0.85 0.33 ± 0.30 9.98 ± 10.4 
Tract length 85.4 ± 19.1 53.3 ± 8.89 26.2 ± 7.47 
 
 
 
 
 
5.4 Inferential statistics on diffusion tensor imaging metrics with age 
 
The statistical results on Pearson correlations (or Spearman correlations) between age and each of the 
DTI metrics analyzed, for the total dataset of 95 subjects, are presented in Table 5.5 and 5.6. Whereas 
the latter shows the results for the correlations between tract length and tract density with age, the former 
shows the results for the correlations between each DTI metric - FA, AD, MD and RD (mean values 
and the remaining 14 histogram metrics) - with age. These tables present the correlation coefficients (r 
for Pearson and rS for Spearman) between each pair, where the statistically significant correlation p-
values are highlighted in color (as described by the caption in Figure 5.18). 
 
Similarly, Table 5.7 and 5.8 shows the linear regressions’ adjusted R-squared of the relationship between 
age and each DTI metric, color-coded by the p-value on the linear regression statistical significance.  
 
 
 
  
Figure 5.18 Color scheme for the statistically significant p-values. 
 
Table 5.5 Pearson or Spearman (marked with an *) correlation coefficients (r or rS) between age and each of the DTI metrics (FA, AD, MD and RD) mean, standard deviation (sd), median, 
trimmed mean, median absolute deviation (mad), minimum, maximum, range, skewness, kurtosis, standard error (se), and the 5th, 25th, 75th and 95th percentiles values, calculated for the male 
urethral complex structures studied. Statistically significant correlation p-values are color-coded, as shown by Figure 5.18. 
 
Table 5.6 Pearson or Spearman (marked with an *) correlation coefficients (r or rS) between age and each of the DTI metrics tract length and tract density, calculated for the male urethral 
complex structures studied. Statistically significant correlation p-values are color-coded, as shown by Figure 5.18. 
Age as independent variable 
Proximal sphincter Distal sphincter Membranous urethra 
Tract length Tract density Tract length Tract density Tract length Tract density 
-0.0008 -0.062* -0.187 -0.121* -0.139* -0.142* 
0.01 < p-value < 0.05 p-value < 0.01 
Age as independent variable Proximal sphincter Distal sphincter Membranous urethra 
FA AD MD RD FA AD MD RD FA AD MD RD 
Mean -0.174 0.171 0.206 0.225 0.363 0.301* 0.301* 0.335* 0.506 0.165* 0.375* 0.966* 
Standard deviation (sd) 0.009 0.172* 0.233 0.227 -0.091 -0.003* 0.007* -0.023 0.041 0.238 0.283 0.269 
Median -0.211 0.091 0.149 0.168 -0.095 0.173* 0.169* 0.175* 0.052 0.116* 0.060* 0.069* 
Trimmed mean -0.189 0.144 0.198 0.216 -0.094 0.151* 0.146* 0.133* 0.071 0.135* 0.080* 0.069* 
Median absolute deviation (mad) -0.029 0.201* 0.256 0.225 -0.175 -0.010* 0.113* 0.062 0.036 0.226 0.275* 0.252 
Minimum -0.273* -0.186* -0.176* -0.153* 0.097* -0.004* 0.018* 0.033* 0.089* 0.088* 0.011* -0.003 
Maximum 0.108* -0.041 -0.114 -0.130 -0.059* -0.129 -0.211* -0.197 -0.011* 0.173* 0.174* 0.128 
Range 0.179* 0.044* -0.040 -0.049* -0.059* -0.114 -0.201 -0.210 -0.020* 0.156 0.148 0.133 
Skewness 0.148* -0.076* -0.181 -0.166 -0.034* -0.100 -0.210* -0.170 -0.052* 0.057* 0.063* 0.033* 
Kurtosis 0.117* -0.204* -0.296* -0.291* -0.016* -0.068* -0.191* -0.191* -0.060* -0.110* -0.159* -0.196* 
Standard error (se) -0.019* 0.066* 0.063* 0.056* 0.072* 0.098 0.100 0.102 0.180* 0.285* 0.289* 0.276* 
5th percentile (Q0.05) -0.237 -0.013* 0.023* 0.061* -0.042* 0.168* 0.102 0.082 0.013 0.057* -0.036* -0.043 
25th percentile (Q0.25) -0.220 0.020 0.078 0.117 -0.063 0.212* 0.136 0.130 0.070 0.054* 0.034* 0.036* 
75th percentile (Q0.75) -0.148 0.226* 0.285 0.278* -0.116 0.135* 0.150* 0.134* 0.081 0.186* 0.142* 0.116* 
95th percentile (Q0.95) -0.077 0.297* 0.268* 0.260* -0.085 0.012* 0.007* -0.011* 0.064 0.176* 0.219* 0.205* 
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Table 5.7 Adjusted R-squared values on the linear regressions performed between age and each of the DTI metrics (FA, AD, MD and RD) mean, standard deviation (sd), median, trimmed mean, 
median absolute deviation (mad), minimum, maximum, range, skewness, kurtosis, standard error (se), and the 5th, 25th, 75th and 95th percentiles values, calculated for the male urethral complex 
structures studied. Statistically significant correlation linear regressions are color-coded, as shown by Figure 5.18. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.8 Adjusted R-squared values on the linear regressions performed between age and each of the DTI metrics tract length and tract density, calculated for the male urethral complex 
structures studied. Statistically significant correlation p-values are color-coded, as shown by Figure 5.18. 
Age as independent variable 
Proximal sphincter Distal sphincter Membranous urethra 
Tract length Tract density Tract length Tract density Tract length Tract density 
-0.0107 -0.0061 0.0283 0.0004 0.0059 0.0063 
Age as independent variable Proximal sphincter Distal sphincter Membranous urethra 
FA AD MD RD FA AD MD RD FA AD MD RD 
Mean 0.020 0.019 0.032 0.040 -0.002 0.001 0.003 0.004 -0.006 0.002 -0.001 -0.010 
Standard deviation (sd) -0.011 0.036 0.044 0.041 -0.002 -0.010 -0.010 -0.010 -0.009 0.047 0.070 0.063 
Median 0.034 -0.002 0.012 0.018 -0.002 0.009 0.012 0.014 -0.008 -0.003 -0.004 -0.003 
Trimmed mean 0.025 0.010 0.029 0.036 -0.002 0.006 0.010 0.010 -0.006 0.001 -0.001 -0.004 
Median absolute deviation (mad) -0.010 0.043 0.055 0.041 0.020 -0.011 -0.004 -0.007 -0.009 0.041 0.066 0.053 
Minimum 0.065 0.017 0.012 0.000 -0.009 -0.011 -0.009 -0.007 -0.007 -0.010 -0.010 -0.011 
Maximum -0.008 -0.009 0.002 0.006 0.006 0.006 0.030 0.029 -0.011 0.012 0.011 0.006 
Range -0.002 -0.010 -0.009 -0.003 0.008 0.002 0.030 0.034 -0.011 0.014 0.011 0.007 
Skewness 0.021 -0.001 0.023 0.017 -0.011 -0.001 0.020 0.018 -0.006 -0.005 -0.007 -0.010 
Kurtosis 0.007 0.064 0.134 0.124 -0.008 -0.004 0.017 0.015 -0.005 -0.011 -0.008 -0.005 
Standard error (se) -0.011 -0.002 0.000 -0.002 -0.003 -0.001 -0.001 0.000 0.010 0.043 0.045 0.039 
5th percentile (Q0.05) 0.046 -0.005 -0.006 -0.010 -0.006 0.009 -0.001 -0.004 -0.011 -0.010 -0.009 -0.009 
25th percentile (Q0.25) 0.038 -0.010 -0.005 0.003 -0.007 0.014 0.008 0.006 -0.006 -0.007 -0.009 -0.010 
75th percentile (Q0.75) 0.011 0.045 0.071 0.076 0.003 0.001 0.011 0.009 -0.004 0.012 0.010 0.005 
95th percentile (Q0.95) -0.005 0.082 0.083 0.081 -0.003 -0.011 -0.010 -0.010 -0.007 0.015 0.024 0.022 
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5.5 Inferential statistics on diffusion tensor imaging metrics by group 
 
ANOVA (or the non-parametric Kruskal-Wallis, marked with an *) statistical test results on the 
comparison of DTI metrics between the four age groups are presented in Appendix Table B. For each 
of the studied structures of the male urethral complex, DTI metrics that have shown statistically 
significant ANOVA test results were graphically represented using boxplots (Figures 5.19 to 5.21). On 
those boxplots is also shown the respective post-hoc t-test results to identify the age decades between 
which the difference has occurred. 
 
 
Figure 5.19 Boxplots representing statistically significant ANOVA (or the non-parametric Kruskal-Wallis) test results on 
DTI metrics of the proximal sphincter between age groups. Post-hoc t-test p-values for each pair of age decades is on the top 
of each figure. 
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Figure 5.20 Boxplots representing statistically significant ANOVA (or the non-parametric Kruskal-Wallis) test results on 
DTI metrics of the distal sphincter between age groups. Post-hoc t-test p-values for each pair of age decades is on the top of 
each figure. 
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Figure 5.21 Boxplots representing statistically significant ANOVA (or the non-parametric Kruskal-Wallis) test results on 
DTI metrics of the membranous urethra between age groups. Post-hoc t-test p-values for each pair of age decades is on the 
top of each figure. 
 
For the subset of the 69 diagnosed patients with PC, BPH or with a negative diagnosis for a prostate 
condition – the HC group –, ANOVA (or the non-parametric Kruskal-Wallis, marked with an *) 
statistical test results for the comparison between disease groups are represented in Appendix Table B. 
For visually describing how each DTI metric differed between disease groups, boxplots were presented 
in Figure 5.22. Those boxplots were created for the variables that significantly changed between groups, 
where ANOVA (or Kruskal-Wallis) and post-hoc t-test p-values were included. 
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Figure 5.22 Boxplots of statistically significant ANOVA (or Kruskal-Wallis) comparisons of DTI metrics between disease 
groups. Here the PC group is represented in red, the BPH in orange and the HC group in green. Post-hoc t-test p-values for 
each pair of disease groups is on the top of each figure. 
 
Afterwards, statistical t-test results (or the non-parametric Mann-Whitney, marked with an *) are 
presented in Appendix Table B, for identifying whether each of the DTI metrics varied with statistically 
significance with cancer status, meaning between patients with and without PC. Boxplots of statistically 
significant t-test comparisons are depicted in Figure 5.23.  
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Figure 5.23 Boxplots of statistically significant t-test comparisons of DTI metrics between cancer status groups. Here the PC 
group is represented in red, whereas the non-PC group is shown in grey. 
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6 DISCUSSION 
 
With an evolving ageing population, there is an increasing risk for several complications, including 
prostate conditions in men. These conditions comprise BPH and PC. PC is the most incident cancer 
among male subjects in developed countries [5], and different treatment options are available according 
to tumor stratification and individual patient preferences. For locally advanced tumors, the RP has 
proven to be the most accurate treatment option in tumor removal, with a longer life expectancy. Despite 
recent innovative advances in RP, including new robotic systems and sparing surgical techniques, the 
rate of post-surgical outcomes is still a major drawback that makes patients avoid surgery. Particularly, 
urinary incontinence is a limiting quality of life outcome that affects a significant proportion of patients 
that undergo surgery [1]. The male urethral complex has shown to play a determining role in maintaining 
urinary continence, and the post-surgical incontinence is mostly related with the removal of the proximal 
sphincter concomitant with prostate removal [41].  
 
Using diffusion tensor imaging (DTI) – an MRI-based technique that studies the fiber arrangements 
based on the diffusivity of water molecules – to extract a set of metrics of the proximal and distal 
sphincters and of the membranous urethra, can reveal its microstructure [3]. Studying how DTI metrics 
– including FA, AD, MD, RD, tract length and tract density – of the male urethral sphincter complex 
change with increasing age, can reveal relevant information for a future prediction of the urinary 
incontinence recovery rate in operated older male.  
 
To our knowledge, the current study was the first to investigate age-related differences in the male 
urethral sphincter. In this investigation, some acquisition and processing steps on DTI of the male 
urethral sphincter complex were optimized and different aspects were analyzed during this study, 
including the acquisition parameters, fiber tracking parameters and eddy currents and motion 
corrections.  
 
 
Optimization of diffusion tensor imaging acquisition parameters for the male urethral sphincter 
 
There is no stablished consensus on the optimal DTI acquisition parameters – it is dependable on several 
factors, including hardware configuration, field strength, vendor, scanning time compatible with the 
clinical practice, and the anatomic structure to be studied [14]. Additionally, it was the first time that a 
DTI sequence was included on the mpMRI of the prostate acquired at CCU. Firstly, a MRI scanner with 
a field strength of 3T was chosen over 1.5T, because the former represents a twofold increase in the 
SNR comparing with the latter, which results in a better spatial and temporal resolution [118]. Secondly, 
in order to define the acquisition parameters that yielded good fiber tracking results for the urethral 
sphincter, a set of different parameters – including the number of gradient directions, the number of 
slices and the b-value – have been tested. Specifically, from case 001’ to case 002’, the number of slices 
was decreased from 25 to 20 in order to minimize acquisition duration, because of time constraints 
imposed by the clinicians. Although in the brain, recommended b-values are in the order of 1000 s/mm2 
[47], reported b-values on DTI studies of the prostate are lower, and around 700 s/mm2 [92]. In fact, 
since the prostate has a lower number of fibers comparing with the brain, a higher b-value may not allow 
an accurate definition of the sphincter structure. So, from case 002’ to 001 we’ve made the decision to 
decrease the b-value from 800 to 600 s/mm2, which allowed a better image resolution. And so, it was 
possible to increase the number of slices while maintaining acquisition duration. From case 001 to 002, 
all parameters were kept constant, but the acquisition extension has been displaced to a more distal 
region, since for this patient’s tracking, it was only possible to delineate half of the distal sphincter. 
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Finally, it was found that a decrease on the number of diffusion encoding directions from 33 to 16 (Case 
003) did not significantly decreased the accuracy on fiber tracking. So, it was simultaneously possible 
to increase the number of acquired slices, while maintaining the in-plane resolution and decreasing the 
acquisition duration. So, it was considered that a DTI sequence with a b-value of 600 s/mm2, 16 diffusion 
gradient directions and 40 acquired slices represented the best compromise between acquisition duration 
and in-plane resolution.  
 
 
Image quality control, regions of interest definition and the choice of fiber tracking parameters  
 
Before fiber tracking, a manual inspection of the individual .src quality control files has shown high 
neighboring DWI correlation values – between 0.53 and 0.95 – which attests to the image quality. Since 
on the contrary, lower correlation values are suggestive of subject motion and other SNR issues [4]. 
Additionally, it was chosen a manual definition of the ROIs to track the sphincters and the membranous 
urethra, instead of an automated approach. For segmenting white-matter of the brain, “virtual dissection” 
– combinations of inclusion and exclusion regions of interest are manually defined on the images in 
order to obtain the fiber tracts – have been replaced by more reproducible and less time-consuming 
automatic approaches [119]. These are comprised by ROI-based, clustering-based and direct 
segmentations, that mostly rely on the comparison with a WM brain atlas. However, the creation of a 
prostate atlas that results on the alignment of all subjects’ glands would present unfeasible anatomical 
results due to the high variability between subjects – namely, subjects under study have very different 
prostate volumes and different status of full/empty bladder –, and the ROIs to track the sphincters in this 
atlas would not match the correct position of the sphincter for each individual subject. 
 
Regarding termination criteria, that includes FA threshold and angular threshold, these were chosen by 
following a trial-and-error approach using as starting point the values stablished by Sinha et al. 2018 
[3]. A FA threshold of 0.15 was chosen, since lower values caused fibers to be tracked outside the 
structures of interest, whereas higher values restrained too much the tracked fibers. For some subjects, 
lower FA thresholds of 0.10 or 0.05 were used in order to include the fibers that are part of the structures. 
Angular threshold defines the maximum crossing angle between consecutive moving directions, above 
which the tracking is terminated. A higher angular threshold (75°) was chosen for the sphincters 
comparing with the membranous urethra (45°), because they represent ring-like structures, that have a 
higher angulation comparing with straight structures like the membranous urethra. Concerning the 
remaining fiber tracking parameters, the step size represents a moving distance of 0.69 mm in each 
tracking interval, and with a smoothing of 0.09, meaning that each moving direction remains 9% of the 
previous propagation vector, or “momentum” [4]. The length of the tracked streamlines was limited to 
the range of 50 to 200 mm, so that spurious shorter fibers as well as long irrelevant fibers are eliminated. 
An “all” seed orientation was chosen over a “primary” seed orientation to start the tracking for each 
fiber orientation within a voxel, and not only for the most prominent fiber. Furthermore, a “subvoxel” 
seed position was chosen over a “voxel” to place unlimited seeds within the voxel, and not only in its 
center. The default deterministic algorithm was chosen for the tracking, with a trilinear direction 
interpolation, since as shown to yield better results than a fourth order Runge-Kutta method. A 
multithread approach (4 threads) was used according to the available computation power, to optimize 
the tracking performance. For determining the tracking termination, seed number was redefined instead 
of tract number, because it was expected to give the tracts some freedom and to set their number based 
on seeds.  
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The effect of the subject motion and eddy currents corrections on fiber tracking results 
 
Subject motion and eddy currents corrections of prostate diffusion tensor images were not performed in 
most existing studies [17], [92], [96], [99]. Despite the inexistence of indications on whether these 
corrections should be performed, the DTI study on the male urethral complex [3] has included some 
processing steps to perform them. In general, the combination of retrospective and prospective methods 
has proven to be the most reliable option to correct for patient movement – in combination with EPI 
distortion and eddy currents correction [68]. A prospective method alters the DTI sequence to include 
real-time motion correction. The real-time motion correction was performed on 17 of the study subjects, 
by an alignment of the diffusion volumes with the b0 using an affine transformation. On the other hand, 
a retrospective correction method is the one that implements several processing steps after the data was 
acquired. For the eddy currents correction, two different methods were used – the combination of 
“topup” with “eddy” from FSL and the DSI Studio eddy/motion correction. Since “topup” requires at 
least two b0 volumes with opposite PE directions it was only possible to calculate the susceptibility 
distortions for the subset of 17 subjects with a PA acquisition. Analyzing the DTI metrics of the 
sphincters and membranous urethra for this subset of patients, it was found no statistically significant 
differences with and without correction. The lack of statistical significance was found both for subject 
motion and eddy currents corrections, which leads to the conclusion that there is no need for correcting 
these images in order to get accurate fiber tracking results for the male urethral sphincter. 
 
 
Investigating age-related differences on diffusion tensor imaging metrics of the male urethral complex 
 
Answering the main research question of this thesis, it was found that for the 95 study subjects analyzed, 
some DTI metrics significantly changed with age. In particular, when correlating each one of the studied 
DTI metrics with age, MD and RD in the proximal sphincter seemed to be positively correlated with 
age. However, since the visual inspection of fiber tracking results has shown local variations in the DTI 
metrics, metrics that explain its distribution along the structure were included. In fact, when analyzing 
other histogram metrics apart from the standard mean DTI metric values, many of these have shown to 
be significantly correlated with age. In particular, for the proximal sphincter, FA minimum, MD and 
RD kurtosis, MD and RD 75th percentiles and AD and MD 95th percentiles, as well as MD and RD 
standard deviations, MD absolute deviation and AD, MD and RD standard errors, for the membranous 
urethra were statistically significant correlated with age. For the distal sphincter, fewer DTI metrics 
were correlated with age, including, for instance, MD maximum, MD skewness, RD range and AD 25th 
percentile. The identified statistically significant linear regressions showed a high agreement with the 
significant correlations found. It is safe to assume that the DTI metrics MD and RD – including its mean 
value and other histogram metrics, specially standard error (se), median absolute deviation (mad), 
kurtosis, standard error (se) and 75th and 95th percentiles – are better correlated with age, and the analysis 
of these metrics distributions can lead to the understanding of the male urethral sphincter microstructure 
with age.  
When dividing patients according to their age, it was found that, although DTI metrics’ mean values did 
not significantly change between age groups, some histogram metrics – including maximum value, 
kurtosis and the 75th percentile – have recurrently differed between age groups, particularly MD and 
RD. Specifically, most of the changes were identified between those aged 50-59 with 70-79, and 50-59 
with 80-89 years old. For example, RD kurtosis in the distal sphincter is significantly decreased in the 
80-year-olds when comparing with the 50-year-olds. This means that RD has a more flattened 
distribution in older subjects, with a similar distribution of diffusion among the distal sphincter.  
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In conclusion, MD and RD distributions significantly changed with age. For instance, with increasing 
age, the RD kurtosis in the proximal sphincter has a more flattened distribution, the MD maximum value 
in the distal sphincter is decreased, and the MD values are highly deviated from its median in the 
membranous urethra. Accordingly, some of these histogram metrics might be used as biomarkers of the 
male urethral complex to differentiate subjects by age.  
 
 
The effect of a prostate condition on diffusion tensor imaging metrics of the male urethral complex 
 
Moreover, hypothesizing that the presence of a prostate condition could affect the DTI metrics, it was 
studied how each of them changed in PC, BPH and HC subjects. Among PC patients, it was assumed 
that the location of the tumor does not compromise the DTI fiber tracking results. When dividing patients 
in two groups by cancer status (with and without PC), statistically significant differences were found, 
for the proximal sphincter, in tract length and in the 5% percentile of FA distribution. Moreover, when 
dividing patients in three disease groups it was found, for the proximal sphincter, that most differences 
in DTI metrics lied within the BPH group. More specifically, tract length was significantly increased in 
patients with BPH comparing with those with PC, and MD skewness and RD skewness were 
significantly decreased in subjects with BPH comparing with the HC. Also, HC could be differentiated 
from the other two groups for having a significantly increased tract density in the distal sphincter.  
 
 
Limitations and future work 
 
Although statistically significant differences were found in some DTI metrics of the proximal sphincter, 
distal sphincter and membranous urethra, further investigations are needed to prove if the presence of a 
prostate condition has influence in those metrics. In fact, one of the main limitations of this study was 
the heterogeneity of the population in terms of disease conditions – some patients have more aggressive 
cancers that others, most older males have some degree of prostatic hyperplasia (even when not 
diagnosed) and almost all HC have negative biopsies despite being in active surveillance for PC. Other 
limitation relies on the small structure size of the urethral sphincter, that may be corrupted by partial 
volume effects. Additionally, there were no subjects with a prostate MR for PC diagnosis with less than 
45 years old during the study period.  
 
However, the subjects analyzed in this study reflect the reality of everyday clinical practice. There is an 
increasing chance in developing any type prostate condition with increasing age. In fact, having more 
than 60 years old is a strong predictor for BPH [120], and represents an incidence of 77.6% of subjects 
that have PC [28]. So, more than using DTI for studying how the sphincter is structured in young healthy 
subjects, it is important to study its microstructure on real prospective patients. 
 
Since the inclusion of an additional DTI sequence to the standard mpMRI, only 14 patients of the 45 
study subjects with PC, were submitted to a RALRP using the newly approved TransDouglas surgical 
technique. Additionally, attending to the reduced time span from the initial acquisitions, most of these 
subjects haven’t yet answered the 6-months, or even the 3-months, post-surgical questionnaires. As a 
consequence, it is not possible to make a prediction on the post-surgical urinary continence time 
recovery with such short number of patients. After having a larger dataset of operated patients, it is of 
interest to correlate the post-surgical test scores with the pre-operative T2-weighted MRI parameters 
and DTI metrics, that reflect the sphincters function and microstructure. In the future, we hope to be 
able to extract these biomarkers for each patient’s urethral sphincter complex and use them as a predictor 
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on the rate of post-surgical incontinence. However, it is important that this model takes into account the 
changes in DTI metrics of the male urethral complex that are influenced by ageing. This predictive 
model may guide patients in an informed choice of the best personalized treatment option to treat their 
prostate tumor, and to simultaneously provide a satisfying quality of life. 
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APPENDIX 
 
 
Table A Mean and standard deviation (mean ± sd) values on the 14 histogram metrics for each of the DTI indices of the 95 
male study subjects, for each analyzed structure of the urethral complex. Histogram metrics regarding diffusivity measures - 
AD, MD and RD – are expressed in 10-3 mm2/s; Histogram metrics regarding FA are dimensionless. 
 Proximal 
sphincter Distal sphincter 
Membranous 
urethra 
FA Standard deviation (sd) 0.0908 ± 0.0186 0.0870 ± 0.0196 0.0802 ± 0.0254 
Median 0.3525 ± 0.0404 0.3025 ± 0.0424 0.3252 ± 0.0494 
Trimmed mean 0.3553 ± 0.0399 0.3086 ± 0.0412 0.3290 ± 0.0475 
Median absolute 
deviation (mad) 
0.0875 ± 0.0179 0.0804 ± 0.0195 0.0801 ± 0.0303 
Minimum 0.0903 ± 0.0295 0.1188 ± 0.0263 0.1438 ± 0.0352 
Maximum 0.8155 ± 0.1221 0.6859 ± 0.1123 0.6149 ± 0.1217 
Range 0.7252 ± 0.1372 0.5671 ± 0.1168 0.4711 ± 0.1191 
Skewness 0.4914 ± 0.3492 0.7618 ± 0.4527 0.3562 ± 0.4978 
Kurtosis 0.5346 ± 0.9719 0.9033 ± 1.7613 0.0106 ± 1.0735 
Standard error (se) 0.0001 ± 0.0001 0.0006 ± 0.0005 0.0004 ± 0.0007 
5th percentile (Q0.05) 0.2240 ± 0.0236 0.1968 ± 0.0280 0.2144 ± 0.0362 
25th percentile (Q0.25) 0.2956 ± 0.0322 0.2522 ± 0.0356 0.2729 ± 0.0420 
75th percentile (Q0.75) 0.4148 ± 0.0491 0.3652 ± 0.0500 0.3856 ± 0.0605 
95th percentile (Q0.95) 0.5211 ± 0.0736 0.4771 ± 0.0734 0.4735 ± 0.0868 
AD Standard deviation (sd) 0.3862 ± 0.1441 0.3764 ± 0.1473 0.2804 ± 0.1290 
Median 2.1496 ± 0.1623 2.0882 ± 0.2043 2.1221 ± 0.3793 
Trimmed mean 2.1596 ± 0.1664 2.1050 ± 0.2085 2.1260 ± 0.3757 
Median absolute 
deviation (mad) 
0.3142 ± 0.0827 0.3274 ± 0.1277 0.2804 ± 0.1512 
Minimum 0.5012 ± 0.4862 0.9853 ± 0.4440 1.2981 ± 0.3534 
Maximum 4.4297 ± 0.9316 3.6830 ± 0.7929 2.9695 ± 0.6820 
Range 3.9286 ± 1.2136 2.6977 ± 0.9186 1.6714 ± 0.6791 
Skewness 0.5375 ± 0.7939 0.4250 ± 0.8026 0.0500 ± 0.5409 
Kurtosis 2.5848 ± 2.8041 1.3442 ± 2.2239 0.0615 ± 1.3894 
Standard error (se) 0.0005 ± 0.0005 0.0025 ± 0.0019 0.0014 ± 0.0033 
5th percentile (Q0.05) 1.6075 ± 0.2071 1.5822 ± 0.2234 1.6919 ± 0.2896 
25th percentile (Q0.25) 1.9416 ± 0.1562 1.8773 ± 0.1838 1.9293 ± 0.3100 
75th percentile (Q0.75) 2.3800 ± 0.2215 2.3304 ± 0.2655 2.3255 ± 0.4578 
95th percentile (Q0.95) 2.8338 ± 0.4139 2.8161 ± 0.5067 2.5952 ± 0.5641 
MD Standard deviation (sd) 0.3198 ± 0.1212 0.3125 ± 0.1190 0.2295 ± 0.0937 
Median 1.5685 ± 0.1479 1.5953 ± 0.1944 1.5739 ± 0.3080 
Trimmed mean 1.5796 ± 0.1530 1.6046 ± 0.1930 1.5738 ± 0.3080 
Median absolute 
deviation (mad) 
0.2511 ± 0.0721 0.2740 ± 0.1068 0.2284 ± 0.1170 
Minimum 0.3332 ± 0.3407 0.6621 ± 0.3342 0.8890 ± 0.2976 
Maximum 3.4632 ± 0.6609 2.8690 ± 0.6722 2.2314 ± 0.4777 
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Range 3.1300 ± 0.8488 2.2069 ± 0.7720 1.3424 ± 0.4782 
Skewness 0.6711 ± 0.7994 0.3311 ± 0.7493 -0.0528 ± 0.5785 
Kurtosis 2.8261 ± 2.6540 1.2507 ± 2.0875 0.0322 ± 1.4025 
Standard error (se) 0.0004 ± 0.0004 0.0021 ± 0.0016 0.0012 ± 0.0027 
5th percentile (Q0.05) 1.1352 ± 0.1852 1.1514 ± 0.2066 1.2064 ± 0.2697 
25th percentile (Q0.25) 1.4036 ± 0.1456 1.4149 ± 0.1774 1.4103 ± 0.2733 
75th percentile (Q0.75) 1.7590 ± 0.2069 1.7940 ± 0.2367 1.7369 ± 0.3593 
95th percentile (Q0.95) 2.1552 ± 0.3603 2.1790 ± 0.4094 1.9457 ± 0.4283 
RD Standard deviation (sd) 0.3137 ± 0.1070 0.3041 ± 0.1052 0.2305 ± 0.0812 
Median 1.2782 ± 0.1485 1.3485 ± 0.1908 1.2975 ± 0.2800 
Trimmed mean 1.2895 ± 0.1526 1.3539 ± 0.1902 1.2966 ± 0.2805 
Median absolute 
deviation (mad) 
0.2575 ± 0.0713 0.2689 ± 0.0928 0.2281 ± 0.1008 
Minimum 0.2137 ± 0.2303 0.4509 ± 0.2635 0.6186 ± 0.2784 
Maximum 3.1345 ± 0.5802 2.5737 ± 0.6093 1.9713 ± 0.4141 
Range 2.9208 ± 0.7023 2.1228 ± 0.6817 1.3527 ± 0.4078 
Skewness 0.6714 ± 0.6797 0.2801 ± 0.6584 -0.0725 ± 0.5717 
Kurtosis 2.2595 ± 2.0937 1.0245 ± 1.7486 0.0170 ± 1.3078 
Standard error (se) 0.0004 ± 0.0004 0.0021 ± 0.0015 0.0012 ± 0.0026 
5th percentile (Q0.05) 0.8526 ± 0.1745 0.8959 ± 0.2017 0.9230 ± 0.2651 
25th percentile (Q0.25) 1.1100 ± 0.1466 1.1673 ± 0.1811 1.1331 ± 0.2645 
75th percentile (Q0.75) 1.4717 ± 0.2003 1.5396 ± 0.2234 1.4586 ± 0.3152 
95th percentile (Q0.95) 1.8600 ± 0.3283 1.8984 ± 0.3676 1.6692 ± 0.3668 
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Table B Analysis of variance (ANOVA) test result on the comparison of each DTI metric for the male urethral complex 
structures studied, between age and disease. Additionally, t-test results on the comparison of DTI metrics between cancer 
status groups. Non-parametric test results are highlighted in light blue, and statistically significant test p-values are color-
coded, as shown by Figure 5.18. 
COMPARISON OF EACH VARIABLE BY GROUP 
Variable 
For 94 subjects For 69 subjects 
AGE GROUP DISEASE GROUP CANCER STATUS 
F value 
/chi-
squared 
p-value 
F value 
/chi-
squared 
p-value t test/ W p-value 
PROX_FA 0.712 0.547 1.032 0.362 1.121 0.269 
PROX_FA_SD 0.344 0.794 0.141 0.869 521 0.817 
PROX_FA_MEDIAN 1.021 0.387 1.648 0.200 1.501 0.141 
PROX_FA_TRIMMED 0.816 0.488 1.216 0.303 1.213 0.232 
PROX_FA_MAD 0.316 0.813 0.194 0.824 523 0.837 
PROX_FA_MIN 6.591 0.086 0.126 0.939 556 0.845 
PROX_FA_MAX 2.759 0.430 2.801 0.246 631 0.256 
PROX_FA_RANGE 3.539 0.316 2.409 0.300 626 0.284 
PROX_FA_SKEW 4.193 0.241 4.896 0.086 419 0.130 
PROX_FA_KURTOSIS 2.567 0.463 0.679 0.712 554 0.866 
PROX_FA_SE 0.828 0.843 0.956 0.620 485 0.495 
PROX_FA_Q0.05 1.029 0.384 1.101 0.339 607 0.405 
PROX_FA_Q0.25 0.872 0.459 1.533 0.224 1.391 0.171 
PROX_FA_Q0.75 0.624 0.601 0.892 0.415 1.003 0.322 
PROX_FA_Q0.95 0.497 0.685 0.191 0.826 0.537 0.595 
PROX_AD 1.730 0.167 0.674 0.513 0.977 0.334 
PROX_AD_SD 2.042 0.564 1.054 0.590 570 0.712 
PROX_AD_MEDIAN 1.154 0.332 1.405 0.253 1.261 0.214 
PROX_AD_TRIMMED 1.604 0.194 1.080 0.346 1.161 0.252 
PROX_AD_MAD 3.494 0.322 0.724 0.489 -0.162 0.872 
PROX_AD_MIN 4.010 0.260 3.005 0.223 470 0.381 
PROX_AD_MAX 1.517 0.215 0.849 0.654 0.864 0.391 
PROX_AD_RANGE 5.763 0.124 0.824 0.443 625 0.289 
PROX_AD_SKEW 0.990 0.804 2.860 0.239 575 0.666 
PROX_AD_KURTOSIS 3.458 0.326 1.254 0.534 625 0.289 
PROX_AD_SE 0.254 0.968 1.297 0.523 478 0.441 
PROX_AD_Q0.05 2.609 0.456 1.549 0.461 621 0.313 
PROX_AD_Q0.25 0.571 0.636 1.178 0.314 1.314 0.197 
PROX_AD_Q0.75 8.310 0.040 2.126 0.345 642 0.203 
PROX_AD_Q0.95 6.231 0.101 0.750 0.687 605 0.419 
PROX_MD 1.898 0.136 0.561 0.573 586 0.569 
PROX_MD_SD 1.160 0.329 0.416 0.661 0.068 0.946 
PROX_MD_MEDIAN 1.240 0.300 1.164 0.319 0.828 0.413 
PROX_MD_TRIMMED 1.888 0.137 0.914 0.406 0.675 0.503 
PROX_MD_MAD 2.251 0.088 4.891 0.087 557 0.837 
PROX_MD_MIN 3.150 0.369 3.120 0.210 463 0.335 
PROX_MD_MAX 1.904 0.135 0.291 0.748 0.757 0.452 
PROX_MD_RANGE 1.635 0.187 1.721 0.423 622 0.307 
PROX_MD_SKEW 0.683 0.565 3.424 0.038 -0.132 0.896 
PROX_MD_KURTOSIS 7.631 0.054 1.728 0.421 608 0.398 
PROX_MD_SE 0.104 0.991 1.542 0.462 493 0.561 
PROX_MD_Q0.05 1.725 0.631 1.425 0.490 612 0.370 
PROX_MD_Q0.25 0.485 0.693 0.483 0.619 621 0.313 
PROX_MD_Q0.75 3.532 0.018 2.042 0.360 595 0.495 
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PROX_MD_Q0.95 4.595 0.204 0.890 0.641 596 0.487 
PROX_RD 1.922 0.132 0.565 0.571 0.323 0.748 
PROX_RD_SD 1.175 0.324 0.397 0.674 0.126 0.901 
PROX_RD_MEDIAN 1.295 0.281 0.920 0.403 0.447 0.657 
PROX_RD_TRIMMED 1.895 0.136 0.847 0.433 0.393 0.696 
PROX_RD_MAD 2.335 0.079 3.979 0.137 565 0.759 
PROX_RD_MIN 2.608 0.456 3.367 0.186 455 0.287 
PROX_RD_MAX 1.855 0.143 0.344 0.710 0.855 0.396 
PROX_RD_RANGE 5.347 0.148 0.475 0.624 632 0.251 
PROX_RD_SKEW 0.854 0.468 3.777 0.028 -0.275 0.785 
PROX_RD_KURTOSIS 8.177 0.042 2.383 0.304 607 0.405 
PROX_RD_SE 0.128 0.988 1.355 0.508 504 0.657 
PROX_RD_Q0.05 1.685 0.640 0.871 0.647 598 0.472 
PROX_RD_Q0.25 0.598 0.301 0.374 0.689 604 0.426 
PROX_RD_Q0.75 9.299 0.026 1.817 0.403 574 0.673 
PROX_RD_Q0.95 4.625 0.201 1.173 0.556 588 0.552 
DIST_FA 0.902 0.443 1.615 0.446 -1.308 0.199 
DIST_FA_SD 1.434 0.238 0.095 0.909 0.397 0.693 
DIST_FA_MEDIAN 0.419 0.740 2.099 0.350 -1.392 0.172 
DIST_FA_TRIMMED 0.741 0.530 1.685 0.431 -1.374 0.178 
DIST_FA_MAD 1.103 0.352 0.761 0.684 586 0.569 
DIST_FA_MIN 2.316 0.509 0.180 0.835 -0.483 0.631 
DIST_FA_MAX 1.145 0.766 0.867 0.648 608 0.398 
DIST_FA_RANGE 1.242 0.743 0.752 0.687 603 0.434 
DIST_FA_SKEW 0.183 0.980 1.204 0.306 582 0.604 
DIST_FA_KURTOSIS 0.247 0.970 0.210 0.900 575 0.666 
DIST_FA_SE 1.896 0.594 2.282 0.110 -0.195 0.846 
DIST_FA_Q0.05 2.004 0.572 5.918 0.052 347 0.015 
DIST_FA_Q0.25 0.306 0.821 3.765 0.152 388 0.056 
DIST_FA_Q0.75 1.130 0.341 0.336 0.845 494 0.569 
DIST_FA_Q0.95 1.636 0.187 0.040 0.980 -0.533 0.597 
DIST_AD 3.704 0.295 1.425 0.491 630 0.262 
DIST_AD_SD 1.486 0.685 0.132 0.936 526 0.866 
DIST_AD_MEDIAN 7.606 0.055 1.005 0.605 615 0.351 
DIST_AD_TRIMMED 5.490 0.139 1.297 0.523 625 0.289 
DIST_AD_MAD 1.699 0.637 0.649 0.723 547 0.935 
DIST_AD_MIN 0.306 0.959 0.117 0.890 556 0.846 
DIST_AD_MAX 3.046 0.033 0.496 0.780 595 0.495 
DIST_AD_RANGE 1.442 0.236 0.126 0.939 556 0.846 
DIST_AD_SKEW 2.139 0.101 0.580 0.748 599 0.464 
DIST_AD_KURTOSIS 2.370 0.499 0.881 0.644 585 0.578 
DIST_AD_SE 0.136 0.939 2.215 0.117 -0.478 0.635 
DIST_AD_Q0.05 6.036 0.110 2.136 0.344 654 0.154 
DIST_AD_Q0.25 10.238 0.017 0.788 0.674 610 0.384 
DIST_AD_Q0.75 2.641 0.450 2.365 0.307 641 0.207 
DIST_AD_Q0.95 1.439 0.696 0.890 0.641 596 0.487 
DIST_MD 3.904 0.272 1.403 0.496 634 0.241 
DIST_MD_SD 1.176 0.759 1.017 0.602 460 0.319 
DIST_MD_MEDIAN 6.558 0.087 0.966 0.617 618 0.331 
DIST_MD_TRIMMED 4.595 0.204 1.257 0.533 629 0.267 
DIST_MD_MAD 0.807 0.848 0.462 0.794 495 0.578 
DIST_MD_MIN 0.782 0.854 0.034 0.967 0.174 0.863 
DIST_MD_MAX 11.943 0.008 0.665 0.717 586 0.569 
DIST_MD_RANGE 3.175 0.028 0.014 0.986 0.034 0.973 
DIST_MD_SKEW 12.067 0.007 0.379 0.827 518 0.788 
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DIST_MD_KURTOSIS 8.155 0.043 0.566 0.753 581 0.612 
DIST_MD_SE 0.210 0.889 2.176 0.122 -0.561 0.578 
DIST_MD_Q0.05 4.317 0.229 1.997 0.368 652 0.161 
DIST_MD_Q0.25 2.065 0.110 0.259 0.773 627 0.278 
DIST_MD_Q0.75 2.660 0.447 1.367 0.505 625 0.289 
DIST_MD_Q0.95 2.775 0.428 0.626 0.731 574 0.675 
DIST_RD 3.278 0.351 1.238 0.538 628 0.272 
DIST_RD_SD 0.871 0.459 0.606 0.739 479 0.449 
DIST_RD_MEDIAN 5.636 0.131 0.805 0.669 611 0.377 
DIST_RD_TRIMMED 3.781 0.286 1.154 0.562 625 0.289 
DIST_RD_MAD 0.401 0.753 0.067 0.967 520 0.807 
DIST_RD_MIN 0.662 0.882 0.024 0.988 549 0.915 
DIST_RD_MAX 5.342 0.002 0.386 0.824 578 0.639 
DIST_RD_RANGE 3.638 0.016 0.003 0.997 0 0.936 
DIST_RD_SKEW 3.473 0.019 0.038 0.963 0 0.780 
DIST_RD_KURTOSIS 8.761 0.033 0.666 0.717 555 0.856 
DIST_RD_SE 0.233 0.873 2.113 0.129 0 0.653 
DIST_RD_Q0.05 1.423 0.241 0.566 0.570 1 0.296 
DIST_RD_Q0.25 1.547 0.208 0.226 0.799 604 0.426 
DIST_RD_Q0.75 2.440 0.254 0.922 0.631 615 0.351 
DIST_RD_Q0.95 3.231 0.486 0.985 0.611 600 0.456 
MU_FA 0.109 0.955 0.033 0.968 -0.253 0.801 
MU_FA_SD 0.186 0.906 0.473 0.625 -0.405 0.687 
MU_FA_MEDIAN 0.184 0.907 0.026 0.974 0.044 0.965 
MU_FA_TRIMMED 0.127 0.944 0.023 0.977 -0.211 0.834 
MU_FA_MAD 0.002 1.000 0.149 0.862 -0.573 0.569 
MU_FA_MIN 1.615 0.656 0.571 0.751 485 0.495 
MU_FA_MAX 1.255 0.740 0.503 0.607 0.221 0.826 
MU_FA_RANGE 0.507 0.917 0.732 0.485 0.576 0.567 
MU_FA_SKEW 2.915 0.405 0.212 0.810 -0.019 0.985 
MU_FA_KURTOSIS 0.255 0.968 2.513 0.285 664 0.120 
MU_FA_SE 2.668 0.446 1.331 0.514 449 0.256 
MU_FA_Q0.05 0.107 0.956 0.322 0.726 0.140 0.889 
MU_FA_Q0.25 0.136 0.938 0.055 0.947 0.320 0.751 
MU_FA_Q0.75 0.115 0.951 0.207 0.813 -0.618 0.539 
MU_FA_Q0.95 0.212 0.888 0.233 0.793 -0.407 0.686 
MU_AD 3.412 0.332 1.784 0.410 639 0.216 
MU_AD_SD 4.526 0.005 1.838 0.167 1.639 0.109 
MU_AD_MEDIAN 2.540 0.468 1.176 0.556 623 0.301 
MU_AD_TRIMMED 3.097 0.377 1.539 0.463 634 0.241 
MU_AD_MAD 2.375 0.075 0.683 0.509 0.979 0.333 
MU_AD_MIN 1.006 0.800 0.384 0.825 583 0.595 
MU_AD_MAX 5.942 0.114 3.647 0.161 671 0.100 
MU_AD_RANGE 1.869 0.140 1.727 0.186 1.799 0.078 
MU_AD_SKEW 0.925 0.819 0.685 0.710 597 0.479 
MU_AD_KURTOSIS 2.178 0.536 0.260 0.878 578 0.639 
MU_AD_SE 7.349 0.062 0.824 0.662 523 0.837 
MU_AD_Q0.05 0.569 0.903 0.936 0.626 616 0.344 
MU_AD_Q0.25 1.127 0.771 1.211 0.546 622 0.307 
MU_AD_Q0.75 4.667 0.198 1.854 0.396 648 0.177 
MU_AD_Q0.95 6.056 0.109 3.179 0.204 672 0.098 
MU_MD 3.128 0.372 1.963 0.375 633 0.246 
MU_MD_SD 3.803 0.013 0.403 0.670 0.803 0.427 
MU_MD_MEDIAN 2.376 0.498 1.398 0.497 623 0.301 
MU_MD_TRIMMED 2.751 0.432 1.628 0.443 625 0.289 
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MU_MD_MAD 3.375 0.022 0.192 0.826 0.215 0.831 
MU_MD_MIN 0.678 0.878 0.322 0.726 579 0.630 
MU_MD_MAX 4.610 0.203 1.433 0.246 1.601 0.116 
MU_MD_RANGE 1.148 0.334 0.901 0.411 1.321 0.193 
MU_MD_SKEW 0.855 0.836 0.972 0.384 0.793 0.432 
MU_MD_KURTOSIS 2.488 0.477 1.619 0.445 638 0.221 
MU_MD_SE 6.371 0.095 0.727 0.695 499 0.612 
MU_MD_Q0.05 0.156 0.926 0.635 0.533 0.876 0.385 
MU_MD_Q0.25 1.528 0.676 1.299 0.522 619 0.325 
MU_MD_Q0.75 3.803 0.284 0.678 0.712 598 0.472 
MU_MD_Q0.95 7.591 0.055 1.827 0.401 638 0.221 
MU_RD 0.161 0.984 0.511 0.774 489 0.527 
MU_RD_SD 2.228 0.090 0.073 0.930 564 0.769 
MU_RD_MEDIAN 2.285 0.515 0.720 0.698 597 0.479 
MU_RD_TRIMMED 2.500 0.475 1.002 0.606 603 0.434 
MU_RD_MAD 2.430 0.070 0.056 0.946 0.089 0.929 
MU_RD_MIN 0.354 0.786 0.630 0.536 0.442 0.661 
MU_RD_MAX 0.831 0.480 1.538 0.222 1.739 0.089 
MU_RD_RANGE 0.611 0.609 0.890 0.416 1.161 0.252 
MU_RD_SKEW 2.159 0.540 1.050 0.356 0.813 0.420 
MU_RD_KURTOSIS 3.918 0.270 2.018 0.365 647 0.181 
MU_RD_SE 5.493 0.139 0.575 0.750 491 0.544 
MU_RD_Q0.05 0.249 0.862 0.811 0.449 0.968 0.338 
MU_RD_Q0.25 1.751 0.626 1.511 0.470 626 0.284 
MU_RD_Q0.75 3.150 0.626 0.512 0.774 565 0.759 
MU_RD_Q0.95 5.809 0.369 1.095 0.578 613 0.364 
PROX_LEN 1.203 0.313 3.415 0.039 2.582 0.013 
PROX_DEN 0.050 0.997 3.501 0.174 497 0.595 
DIST_LEN 4.281 0.233 2.314 0.315 564 0.769 
DIST_DEN 0.346 0.792 4.051 0.021 0.311 0.758 
MU_LEN 2.932 0.402 1.306 0.521 629 0.267 
MU_DEN 1.454 0.693 1.227 0.541 567 0.740 
 
 
 
